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ABSTRACT
The Identification and Characterization of 
Protein Tyrosine Phosphatases 
Expressed in the Developing Rat Brain
Mustafa Sahin 
1995
Previous studies of the deveioping nervous system have shown that cell- 
ceii and celi-matrix interactions are involved in a variety of processes such as 
the proliferation, migration and differentiation of neurons. While many cell 
surface molecules have been identified, the signal transduction mechanisms 
through which they alter cellular responses are poorly understood. Recent 
studies have described a new and large family of enzymes, protein tyrosine 
phosphatases (PTPases), that may play a key role in transduction of cell surface 
events. Opposing the actions of protein tyrosine kinases (PTKs), PTPases may 
determine the state of tyrosine phosphorylation of a protein and regulate its 
function. Within the family of PTPases, two subgroups have been characterized: 
low molecular weight cytoplasmic (non-receptor) PTPases and high molecular 
weight transmembrane (receptor) PTPases. Receptor PTPases have fibronectin 
type III and/or immunoglobulin-like domains in their extracellular domains, 
suggesting that they may have dual functions: cell adhesion and signal 
transduction. Such molecules may play a role in cellular recognition events that 
mediate the accurate assembly of the nervous system.
Using PCR with degenerate primers and a neonatal rat cortex cDNA 
library, we have identified seven PTPases expressed in the developing rat 
brain. Four of these are transmembrane PTPases: LAR, LRP, RPTPyand
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CPTP1. Three are non-receptor PTPases: PTP-1, P19-PTP and SHP. Within the 
embryonic and early postnatal brain, the seven PTPases have overlapping, yet 
unique distributions. The expression of each of these genes are regulated in a 
temporally and spatially restricted pattern. Two PTPase genes, CPTP1 and 
P19-PTP, are expressed in a developmentally-regulated pattern. These two 
PTPases are expressed at their highest levels during neurogenesis and 
neuronal differentiation and are markedly down-regulated during postnatal life. 
Both CPTP1 and P19-PTP are widely distributed in the developing brain. In 
contrast, a non-receptor protein tyrosine phosphatase, PTPH1, is found in a 
region-specific pattern. PTPH1 is expressed in all adult thalamic nuclei 
generated by the dorsal thalamus and is absent in the nuclei generated from 
the ventral thalamus.
The abundance and differential regulation of PTPase genes expressed 
in the developing brain suggest that they play a role in cell-cell interactions 
mediating neural differentiation. The comparative analysis of the expression 
patterns presented in this dissertation can guide further biochemical and 
genetic experiments that would allow a better understanding of their precise 
cellular function.
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GENERAL INTRODUCTION
The mammalian central nervous system (CNS), more than any other 
tissue, contains many distinct regions, each containing a large number of 
different cell types with highly specialized functions. One of the greatest 
challenges in neurobiology today is to understand how the regional and cellular 
diversity of the adult CNS is generated from a neural tube composed of an 
morphologically homogeneous group of progenitor ceiis. Recent evidence 
suggest that cellular interactions during the proliferation, migration and 
differentiation of cells in the developing nervous system play a role in the 
generation of cellular diversity. Such interactions start with the neuronal 
progenitor cells that are located in spatially restricted zones in the embryonic 
brain. These progenitors first undergo a phase of proliferation during which the 
rate of proliferation and identity of the progeny are regulated by cell-cell 
interactions (Gao et al., 1991; McConnell and Kaznowski, 1991). Subsequently, 
post-mitotic neurons migrate to their final position in the neuraxis and extend 
neurites. Both migration and axon elongation are mediated by interactions with 
adjacent cells and matrix (Rakic et al., 1994; Kapfhammer and Schwab, 1992). 
Finally, the mature regional identity of neurons is established; because the 
patterns of connectivity and molecular phenotype can be altered by 
transplanting areas of the brain to ectopic locations, these mature features are 
also determined, at least in part, by intercellular cues (O'Leary and Stanfield, 
1989; Schlaggar and O'Leary, 1991; Barbe and Levitt, 1991). While the 
determination of neuronal phenotype by cell-cell interactions throughout 
development is well established, the molecular mechanisms involved in these 
processes are iargely unknown.
Cell-cell interactions and their effects on cellular phenotype are mediated
1
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by cs!! surface molecules and associated second messenger systems. While 
the cell surface molecules have been thought of previously as "cell adhesion 
molecules", the identification and characterization of increasing numbers of 
such molecules has made it increasingly clear that the function they perform is 
not merely a matter of extracellular "stickiness", but is a complex phenomenon 
involving transmembrane signaling and cytoplasmic responses. The 
significance of cell surface proteins in signal transduction has been 
demonstrated most clearly in the immune system. For example, in the 
interaction between leukocytes and endotheiium, initial adhesion leads to 
"activation" of the leukocytes which is mediated by second messengers 
(Springer, 1990; Butcher, 1991). Similarly, the binding of helper T cells to 
antigen presenting cells is followed by a cytoskeletal reorganization that is 
regulated by phosphorylation (Kupfer and Singer, 1989). In the nervous system, 
as well, many cellular processes are regulated by protein phosphorylation, 
balanced by the competing activities of protein kinases and phosphatases. In 
fact, genetic studies in Drosophila illustrate that cell adhesion and protein 
phosphorylation can reflect two components of a single process (Elkins et al., 
1990).
In order to understand the molecular basis of cellular interactions during 
neural development, it is necessary to identify and characterize the proteins that 
mediate cell surface recognition and that transduce signals from the cell surface 
to the cytoplasm. One family of proteins that can fulfill both functions is the 
receptor protein tyrosine phosphatases (PTPases). This dissertation explores 
the identity and the expression patterns of PTPases found in the developing rat 
brain. In this introduction, first I will briefly review the role of tyrosine 
phosphorylation in the developing nervous system and then focus on the 
PTPase family. Chapter 1 describes the PCR-based approach that we used to
2
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identify seven PTPases from newborn rat neocortex and compares their 
expression patterns. Chapter 2 focuses on two of the seven PTPases identified 
in the first chapter and characterizes their expression patterns throughout 
neural development. Chapter 3 examines the expression of a non-receptor 
PTPase that is particularly enriched in the rat thalamus. Finally, the dissertation 
concludes with a discussion of each of the PTPases studied in this work and 
some concluding remarks about future experiments elucidating the role of 
PTPases in neural development.
TYROSINE PHOSPHORYLATION DURING DEVELOPMENT: THE 
STORY OF KINASES
Regulation of protein function through tyrosine phosphorylation is critical 
in the control of many developmental events, including cellular proliferation and 
differentiation. The state of tyrosine phosphorylation is determined by the 
opposing actions of protein tyrosine kinases (PTKs) and PTPases. In the last 
several years, a growing number of PTKs and PTPases have been identified in 
various species and tissues, including the mammalian CNS. Recently, research 
from several different areas has converged to begin to elucidate the roles 
played by PTKs.
First, studies of growth factors and their receptors have markedly 
advanced our understanding of the functional significance of PTKs. The trk 
family of tyrosine kinases, first identified as genes with oncogenic potential, are 
now known to function as high affinity neurotrophin receptors (Chao, 1992). In 
addition, the receptors for other peptide growth factors, such as (3-PDGF, basic 
FGF, EGF and IGF-I, are also transmembrane PTKs and are expressed in 
neural tissues (Schlessinger and Ullrich, 1992; Chao, 1992). The effects of 
these growth factors on PC12 cells indicate that they, too, may play a role in
3
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neura! development (Heasley and Johnson, 1982). More recently, another 
group of receptor PTKs, the neu oncogene and its homologs, have been 
identified as the receptors for the neuregulin family of neural differentiation 
factors, such as ARIA (Peles and Yarden, 1993).
Second, mutations in several PTK genes in Drosophila cause 
aberrations in neural development (reviewed in Shilo, 1992). Several 
Drosophila mutants indicate that receptor PTKs are crucial for determining the 
identity of neuroblasts in the CNS [faint little ball (Schejter and Shilo, 1989)], 
establishing the number and spacing of photoreceptors in the eye imaginal disc 
[ellipse (Baker and Rubin, 1989)], differentiation of the photoreceptors 
[sevenless (Rubin, 1991)], and glial migration [breathless (Klambt et al., 1992)]. 
In addition, a trk-like Drosophila protein, Dtrk, promotes homophilic cell 
adhesion (Pulido et al., 1992).
Third, non-receptor PTKs (src, fyn, yes) are enriched in growth cones 
(Maness, 1992; Rudd et al., 1993) suggesting that they play a role in neurite 
outgrowth. Recent experiments using transgenic mice in which each of these 
PTKs have been knocked-out strongly suggest that each kinase has a distinct 
and non-redundant role in mediating axonal growth in response to specific cell 
adhesion molecules. For example, src is essential for L1-mediated axonal 
growth while fyn plays a similar role in intracellular signaling initiated by NCAM 
(Ignelzi et al., 1994; Beggs et al., 1994).
Finally, using a PCR based approach, several groups have identified 
novel putative PTKs that are expressed preferentially in the developing CNS 
(Lai and Lemke, 1991; Sanchez et al., 1994). One large family is the eph family 
of transmembrane PTKs some members of which are expressed in a segmental 
pattern in the hindbrain rhombomeres (Nieto et al., 1992; Henkemeyer et al., 
1994; Becker et al., 1994). Until recently, this family of PTKs were orphan
4
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receptors. However, a family of transmembrane moiecuies are now identified as 
ligands for eph kinases (Cheng and Flanagan, 1994; Beckmann et al., 1994). In 
summary, there is ample evidence that PTKs play an important role in neural 
development. In contrast, much less is known about the PTPases.
PTPase FAMILY
The hallmark of the PTPase family is the presence of a conserved 
catalytic domain that preferentially dephosphorylates proteins on tyrosine 
residues. The catalytic domain was first identified because of sequence 
homology between the first biochemically purified cytoplasmic PTPase (PTP- 
1B) and a lymphocyte transmembrane protein of previously unknown function, 
CD45 (Charbonneau et al., 1989). CD45 was subsequently shown to possess 
PTPase activity (Tonks et al., 1988), and this activity was associated with a 230 
amino acid catalytic domain (Fischer et al., 1991). This then led to a search for 
other PTPases by PCR and low stringency hybridization. The PTPases 
identified so far fall into two major groups depending on whether or not they 
have a membrane spanning region. The non-receptor (cytoplasmic) 
PTPases are small molecules with only a single catalytic region and lacking a 
transmembrane domain. In contrast, the receptor (transmembrane) 
PTPases are larger molecules with a large extracellular domain, a single 
transmembrane domain and, in almost all cases, two tandem catalytic domains 
in the intracellular, C-terminal region of the protein. Two exceptions, human 
PTPp and Drosophila DPTP10D, have only one catalytic domain. Deletional 
and mutational analyses indicate that most of the catalytic activity is associated 
with the first (membrane-proximal) domain (Streuli et al., 1990; Desai et al., 
1994). The second (C-terminal) domain may have some catalytic (Tan et al., 
1993) and/or regulatory activities (Streuli et al., 1990). In contrast to the very
5
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high degree of homology in the intracei'iuiar domains of the receptor PTPases, 
the extracellular regions are strikingly divergent in size and structure. The 
extracellular domains of some receptor PTPases resemble cell adhesion 
molecules, containing immunoglobulin (Ig)-like and fibronectin type III (FN III)- 
like repeats. In fact, like other proteins with Ig- and FN Ill-like domains, two 
receptor PTPases, PTPp and PTPk, demonstrate homophilic binding activity 
(Brady-Kalnay et al., 1993; Gebbink et al., 1993; Sap et al., 1994). It is therefore 
tempting to speculate that receptor PTPases piay duai roles, as cell adhesion 
and signal transduction molecules.
Since phosphorylation is a reversible process mediated by both the 
addition and removal of phosphate groups, it is likely that PTPases, just like 
PTKs, will have significant functions in the developing CNS. Given the possible 
function of PTPases in determination of cellular phenotype and our lab's 
interest in the generation of cellular diversity in the mammalian CNS (Hockfield 
and McKay, 1985; Hockfield and Sur, 1990; Martin et al., 1992), I have 
examined the expression of PTPases in the rat CNS during development. The 
results of this work are presented in the next three chapters and are discussed 
within the framework of the explosive progress that has occurred in the PTPase 
field in the last six years.
6
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SEVEN PROTEIN TYROSINE PHOSPHATASES ARE 
DIFFERENTIALLY EXPRESSED IN THE DEVELOPING RAT BRAIN
SUMMARY
Regulation of protein function through tyrosine phosphorylation is critical 
in the control of many developmental processes such as cellular proliferation 
and differentiation. Growing evidence suggests that tyrosine phosphorylation 
may also regulate key events in neural development. While a large body of data 
has demonstrated that protein tyrosine kinases play an important role in neural 
development, much less is known about their counterparts, protein tyrosine 
phosphatases (PTPases). Using PCR with degenerate primers and a neonatal 
rat cortex cDNA library, we have identified seven PTPases expressed in the 
developing rat brain. Four of these are transmembrane PTPases: LAR, LRP, 
RPTPyand CPTP1. Three are non-receptor PTPases: PTP-1, P19-PTP and 
SHP. Northern hybridization analysis demonstrates that only CPTP1 is 
preferentially expressed in neural tissues while the others are found abundantly 
in non-neural tissues as well as in the brain.
Within the embryonic and early postnatal brain, the seven PTPases have 
overlapping, yet unique distributions. For example, LAR mRNA is highly 
expressed by both proliferating and post-mitotic cells in the cerebral cortex at 
embryonic day 17 and in all layers of the cortex at postnatal day 4. In contrast, 
RPTPy mRNA is expressed by post-mitotic neurons in the embryo and 
predominantly by neurons in the superficial layers of the postnatal cortex.
Several of the PTPases examined here are expressed at very high levels 
in the embryonic cortical plate and postnatal neocortex, including the suDpiaie
7
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and subventricular zone. The spatial and temporal regulation of PTPase gene 
expression suggest that these PTPases have important roles in signal 
transduction during early neuronal differentiation and neural development.
8
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One of the most ubiquitous intracellular signaling systems is 
phosphorylation of proteins on serine, threonine and tyrosine residues. 
Regulation of protein function through tyrosine phosphorylation is known to be 
critical in the control of many developmental processes, including cellular 
proliferation and differentiation. Growing evidence suggests that tyrosine 
phosphorylation and dephosphorylation may also play key roles in neural 
development (Wagner et al., 1991). The opposing actions of protein tyrosine 
kinases (PTKs) and protein tyrosine phosphatases (PTPases) determine the 
state of protein tyrosine phosphorylation. A growing number of PTKs and 
PTPases have been identified in various species and tissues, including the 
mammalian central nervous system (CNS).
While new members of the PTPase family are being cloned and 
sequenced at a rapid pace, the physiological roles played by these newly 
identified enzymes remain largely unknown. One possibility is that PTPases act 
as negative regulators and directly oppose the actions of protein tyrosine 
kinases (PTKs) (Brown-Shimer et al., 1992). However, they can also take part in 
the same pathway as PTKs and work in concert them. For instance, the Ick and 
fyn tyrosine kinases are activated when they are dephosphorylated by CD45 
(Koretzky, 1993). Another receptor PTPase, LRP, can similarly regulate the 
activity of src kinase (Zheng et al., 1992). Furthermore, receptor PTKs can 
associate with and activate non-receptor PTPases by phosphorylation, as seen 
in the case of syp (Vogel et al., 1993). Given the abundance, diversity and 
significance of PTK expression in the developing CNS (Lai and Lemke, 1991), it 
is tempting to postulate that the involvement of the PTPases will prove to be
i a i a I  r s r s  l a i ^ l loiuvtai ao won.
9
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Growing evidence suggests that PTPases piay key roies in neurai 
differentiation and axonal outgrowth. NGF-induced neuronal differentiation of 
PC12 cells, for instance, is associated with a dose-dependent increase in 
PTPase activity (Aparicio et al., 1992). In addition, the expression of a receptor 
PTPase (LRP) is up-regulated during neuronal differentiation of embryonal 
carcinoma and neuroblastoma cell lines. Overexpression of LRP in an 
embryonal carcinoma cell line results in a higher fraction of cells undergoing 
neuronal differentiation (Den Hertog et al., 1993). Finally, three receptor 
PTPases are differentially expressed on subsets of developing axons in 
Drosophila. Following the completion of axonogenesis, the mRNAs for all three 
PTPases are down-regulated (Yang et al., 1991; Tian et al., 1991; Hariharan et 
al., 1991). Consistent with a role for PTPases in mammalian neural 
development, the overall level of tyrosine phosphorylation indicates that 
PTPases are particularly active in the late embryonic brain (Maher, 1991).
Because of our interest in the generation of cellular diversity and 
connectional specificity in the developing nervous system, we examined the 
expression of PTPases in the neonatal rat CNS. We have reported the 
identification of two PTPases that are expressed at high levels in the neonatal 
rat cortex and thus are named Cortex-enriched Protein Tyrosine Phosphatases 
(CPTPs) (Sahin and Hockfield, 1993; see chapter 2). This chapter describes the 
indentification of five other PTPases that are found in the neonatal rat 
neocortex. Although these five PTPases were previously cloned from other 
tissues, their expression in the developing cortex had not been examined. Here 
we used northern hybridization to determine whether any of the seven PTPases 
is expressed in a neural-enriched and/or developmentally-regulated pattern.
We aiso performed a detailed comparative in situ hybridization analysis of 
expression patterns of all seven PTPases in the pre- and early post-natal brain.
10
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Our analysis shows that some PTPases are down-regulated over the course of 
cortical development while others are up-regulated. Differential spatial and 
temporal expression of the seven PTPases suggest that they play distinct roles 
in various stages of neural development.
MATERIALS AND METHODS 
RNA extraction and cDNA library synthesis
Total cellular RNA was extracted from occipital cerebral cortex of 
postnatal day zero (PO) Sprague-Dawley rats using the guanidine 
thiocyanate/cesium chloride ultracentrifugation method (Bothwell et al., 1990). 
Poly A+ RNA was isolated by one pass through an oligo dT cellulose (type III, 
Collaborative Research) affinity column (Sambrook et al., 1989). Oligo dT 
primed cDNA synthesis was carried out with the Superscript Plasmid kit 
(GIBCO/BRL). Briefly, the kit uses a Not I primer-adapter and RNaseH' M-MLV 
reverse transcriptase for the first strand and E. coli RNase H, DNA pol I and 
DNA ligase for the second strand synthesis. Double stranded cDNA was blunt- 
ended with T4 DNA pol, cut with Not I and size fractionated by column 
chromatography. cDNAs larger than 500 base pairs (bp) were ligated 
directionally into a modified Bluescript vector, E61, gift of J.L.R. Rubenstein 
(Rubenstein et al., 1991). The cDNA library contained 3.2x10® clones with an 
average insert size of 900 bp.
PCR Amplification
The cDNA library was used as a template for amplification using Taq 
polymerase (GeneAmp, Perkin Elmer) and degenerate primers (see Figure 1 for 
position and sequence of primers). Twenty five pmol each of sense and 
antisense primers were used in 25 pi reactions in Taq buffer (10 mM Tris-HCI
11
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pH 8.3, 50 mM KC!, 1.5 mM MgCfe, 0.001% gelatin) with 0.6 units of Taq 
polymerase, 200 pM dNTPs and 25 ng of cDNA library as template. PCR was 
carried out in a Perkin Elmer DNA Thermal Cycler for 35 cycles. The first five 
cycles of PCR included a 30 sec denaturation at 94°C, 1 min annealing at 37°C, 
a slow ramp (1° every 4 sec) to 72° and 3 min extension at 72°C. The next 30 
cycles ran as follows: 94° for 30 sec, 50° for 1 min and 72° for 2 min. Amplified 
PCR fragments were then ligated without size selection into the pCRII vector 
(Invitrogen). Since our initial low stringency PCR screen yielded many ciones 
that were not homologous to PTPases (Sahin and Hockfield, 1993), we utilized 
an additional re-screening step using a conserved internal primer. This internal 
primer was based on the amino acid sequence KC(D/A)(K/E/Q)YWP and had 
the following oligonucleotide sequence: 5'-
AA(A/G)TG(C/T)G(A/C)(C/T)(A/C/G)A(A/G)TA(C/T)TGGCC-3'. PCR was 
performed with the internal primer and the original downstream primer for 30 
cycles (of 94° for 30 sec, 50° for 1 min and 72° for 2 min each). The 
transformants that were positive by this re-screen were then sequenced by the 
dideoxy chain termination method (Sequenase, U.S. Biochemical) on both 
strands using M13 reverse and T7 primers. Sequence analyses were 
conducted using GCG software (Genetics Computer Group, 1991). The PCR 
clones were then used for the northern and in situ hybridization analyses as 
described below.
Northern hybridization
Total cellular RNA was extracted from various tissues of Sprague-Dawley 
rats using the guanidine thiocyanate/cesium chloride ultracentrifugation method 
(Bothwell et al., 1990). For the analysis of developmental regulation, the 
cerebral cortex was dissected from animals at embryonic day 16 (El 6),
12
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postnatal day 0 (PO), P4, PI 4, P30 and adult, using care to exclude ine 
underlying diencephalon and the hippocampus. Total RNA was also extracted 
from P35 liver as a non-neural control. Twenty five pg of total RNA from each 
sample was resolved by electrophoresis on a 1% agarose gel containing 2.2 M 
formaldehyde and 1X MOPS buffer, and transferred to Zeta-probe (Bio-Rad) by 
capillary blotting. Blots were pre-hybridized in 7% SDS, 1% BSA, 0.5 M 
phosphate buffer pH 6.8 (PB), 1 mM EDTA for 1 hour at 65°C. Hybridization was 
carried out in the same solution for 18 hours at 65°C. Hybridization solution 
contained 1.2 x 106 cpm/ml of probe made by random primed labeling. After 
hybridization, the blot was washed twice in 5% SDS, 0.5% BSA, 40 mM PB, 1 
mM EDTA and twice in 1% SDS, 40 mM PB, 1 mM EDTA at 65°C for 20 
minutes each. RNA molecular weight standards (GIBCO/BRL) were also run on 
the blots to estimate the sizes of the transcripts. Cyclophilin, which is expressed 
at a constant relative abundance throughout brain development, was used as a 
control for equal loading of lanes (Lenoir et al., 1986).
For the analysis of tissue distribution, northern blots containing RNA from 
various tissues of adult Sprague-Dawley rats and several cell lines were 
generously supplied by Dr. Eric Bellefroid, Yale University. Extraction of RNA 
and northern blotting were performed as described above. Each lane of the 
blots contained 20 pg of total RNA. Equality of loading levels was confirmed by 
adding ethidium bromide to each RNA sample and visualizing the 28S and 18S 
rRNAs under UV illumination. The blots were then hybridized and washed as 
described above and exposed to Amersham Hyperfilm between two intensifying 
screens for 1-7 days.
In situ hybridization
In situ hybridization was performed as in Martin et ai. f1yy<ij with
13
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modifications. Twelve micron frozen sections were thaw-mounted onto gelatin 
coated slides and post-fixed in 0.1 M sodium phosphate buffered 4% 
paraformaldehyde (pH 7.4). Sections were rinsed in 1X PBS (137 mM NaCI, 2.7 
mM KCI, 10 mM Na2 HP0 4 , 1.8 mM KH2 PO4 ), 2X SSC and acetylated with 
0.5% acetic anhydride in 0.1 M triethanolamine (pH 8.0). Sections were then 
rinsed in 2X SSC, 1X PBS, dehydrated in ethanols and delipidated in 
chloroform. Sections were prehybridized in 2X SSC, 50% formamide at 50°C 
for 1 hr, and then hybridized in 50% formamide, 1X Denhardt's, 0.75 M NaCI, 
10% dextran sulfate, 30 mM DTT, 10 mM Tris-HCI pH 7.5,1mM EDTA, 0.5 
mg/ml tRNA, 100 pg/ml salmon sperm DNA and 1 x106 cpm probe at 50°C for 
12-15 hours. The [35S]-CTP (NEN) labeled cRNA probes were generated using 
the T7 or SP6 promoters in the TA vector and the Riboprobe system (Promega). 
Following hybridization, slides were treated with 20 pg/ml RNase A, washed in 
2X SSC, 50% formamide, 0.1% BME at 58°C and in 0.1 X SSC/0.1% BME at 
65°C for 30 min each. In order to provide a more accurate comparison of 
expression patterns, all of the probes were hybridized and washed 
simultaneously under identical conditions. Slides were then exposed to 
Amersham Hyperfilm for 1-9 days. Autoradiograms were used as negatives to 
print the figures. For higher resolution, the slides were dipped into NTB-2 
emulsion (Kodak) and developed after 7-28 days. Some slides were counter 
stained with cresyl violet to visualize cytoarchitectonic details.
RESULTS 
PCR from a P0 cortex library resulted in the identification of seven 
PTPase domains.
To identify PTrases expressed in neonatai rat cortex, PCR amplification
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was carried out with primers corresponding to ihe conserved catalytic domains 
of previously reported receptor PTPases. Oligonucleotide primers 
corresponding to amino acid sequences DFWRM(I/V)W (upstream) and 
HCSAGVG (downstream) were synthesized using most common codon usage 
tables to reduce degeneracy (Lathe, 1985) (Fig. 1). A postnatal day zero (PO) rat 
neocortex cDNA library was used as the DNA template for the amplification. The 
initial PCR performed with low stringency annealing conditions yielded many 
clones without any homoiogy io PTPase domains (Sahin and Hockfieid, 1993). 
Therefore, a re-screening step using an internal PCR primer was used to 
eliminate PCR products lacking the highly conserved PTPase sequence.
Indeed, only 35 out of 62 original PCR clones were positive with this secondary 
screen. Subsequent sequence analysis showed that 33 of these 35 encoded 
PTPase domains.
The 33 clones can be sorted into seven different groups, each 
corresponding to a previously identified PTPase (Fig. 2). The first four groups 
(representing 21 of the clones) correspond to either the first or second catalytic 
domains of four receptor PTPases. The remaining three groups (representing 
12 clones) correspond to the single catalytic domain of three non-receptor 
PTPases.
The first group consists of six clones which are 100% identical to the first 
catalytic domain and one clone which is identical to the second domain of rat 
LAR (Leukocyte common Antigen Related protein) (Pot et al., 1991; Yu et al.,
1992). The second group consists of seven identical clones with sequences that 
match the first domain of rat LRP (Leukocyte common antigen Related 
Phosphatase) (Moriyama et al., 1992). The third group of five clones represents 
CPTP1, a receptor PTPase we and others have described recently (Sahin and 
Hockfieid, 1993; see chapter 2; Walton et al., 1993; Pan et al., 1993; Yan et al.,
15
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1993). Two clones are identical to the first domain of CPTP1 and three to its 
second domain. Finally, the fourth group has two identical clones that show 
90% nucleotide identity to the first catalytic domain of mouse RPTPy (Barnea et 
al., 1993), and 71% identity to human PTP£ (Krueger and Saito, 1992). In their 
deduced amino acid sequence, these clones are 97% identical to mouse 
RPTPy, and thus probably represent the rat homologue of this gene.
The remaining 12 clones comprise three groups, each of which 
corresponds to a non-receptor PTPase. The eight clones in ihe first group are 
identical to PTP-1, originally isolated from the rat hypothalamus (Guan et al., 
1990). PTP-1 is the rat homolog of PTP-1 B originally identified from human 
placenta (Charbonneau et al., 1989). The second group contains three clones 
identical to CPTP2, which we have reported (Sahin and Hockfieid, 1993, see 
chapter 2). Since the full-length sequence of this PTPase has been named P19- 
PTP (Den Hertog et al., 1992), we will refer to it by this name in the rest of this 
chapter. Finally, one copy of a PCR sequence was identified with 96% 
nucleotide identity to mouse SHP (SH2-domain Phosphatase) (also known as 
PTP1C and HCP; Shen et al., 1991; Matthews et al., 1992; Yi et al., 1992).
Northern hybridization demonstrates that different PTPases have 
different developmental expression patterns in the cortex.
Representative clones from each group were used to characterize the 
expression patterns of the seven PTPases. Since the homology among 
PTPases in the first catalytic domains is usually less than that in the second 
(Streuli et al., 1990; Sahin and Hockfieid, 1993), we used the first catalytic 
domains as probes in order to minimize the probability of cross-hybridization to 
other PTPases. We focused on LAR and CPTP1, the PCR clones that showed 
the highest sequence identity (74%), to confirm the specificity of our probes and
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to rule out cross-reactivity. Even at 74% homology, the calculated melting 
temperature of CPTP1-LAR hybrids is lower than the stringency conditions used 
for the hybridization. The hybridization patterns of the two probes do not change 
when the stringency of the hybridization is increased by raising the wash 
temperature to 70°C. Therefore, even in the case of the two most homologous 
genes, the PCR clones that we used as probes for northern and in situ 
hybridization analyses are specific for their respective genes, and the signals 
that they generate do not represent cross-hybridization.
The expression patterns of the seven PTPases during cortical 
development were examined using northern blots of RNA isolated from rat 
cerebral cortex of different ages. This analysis confirmed the PCR results, that 
all seven PTPases are expressed in the developing cortex (Fig. 3A). In fact, for 
several receptor PTPases (LAR, RPTPy, CPTP1) multiple transcripts, each with 
a distinctive time course of expression, are present in the cortex.
LAR has three major transcripts with approximate sizes of 4.0, 6.0 and 
8.0 kb. The ratio of expression of these three transcripts changes during cortical 
development. In the embryonic brain, the 4.0 kb band is the most abundant. 
During development, the 8.0 kb transcript is substantially up-regulated, and 
reaches a peak in the adult cortex, where it is the most abundant form. The 6.0 
kb transcript has the lowest intensity at all ages. None of the three bands is 
readily detectable in RNA from P35 liver.
In contrast to LAR, LRP is encoded by a single transcript in the cortex 
(Fig. 3A). The mRNA, which is around 3.5 kb, remains at a roughly constant 
level throughout cortical development. The P35 liver does not contain any LRP 
message that can be detected by this analysis
Trie northern biot anaiysis for RPTPy shows two major high molecular 
weight transcripts, at approximately 7.0 and 9.0 kb, and two minor transcripts at
17
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approximately 4.3 and 3.3 kb (Fig. 3A). The two major transcripts display 
roughly parallel temporal regulation patterns, both reaching their highest levels 
in the second postnatal week and then gradually declining to adult levels. The 
3.3 kb mRNA is detected at moderate levels at E16 and is then markedly down- 
regulated postnatally. The 4.3 kb mRNA does not appear to be temporally 
regulated.
CPTP1 and P19-PTP, whose developmental expression patterns will be 
described in detail in Chapter 2, are included in Figure 3A for comparison. 
Briefly, CPTP1 is encoded by two major transcripts around 6.5 and 7.8 kb. The 
higher molecular weight mRNA predominates in the embryonic cortex and is 
down-regulated during development. The 6.5 kb message appears only 
postnatally in the cortex and becomes the more abundant form by around P14 
and remains so in the adult cortex. In contrast, the P19-PTP probe recognizes a 
single transcript around 3.5 kb. The mRNA for this non-receptor PTPase is 
expressed at highest levels at E16 and is down-regulated to its adult level 
shortly after birth.
The mRNA species recognized by the PTP-1 probe is approximately 4.5 
kb (Fig. 3A). It is detected as early as E16 in the cortex and is slightly down- 
regulated through postnatal life. In contrast to the other PTPases, SHP mRNA is 
more abundant in the liver than it is at any age in the cortex. The expression 
level of the 2.4 kb SHP transcript remains essentially constant during cortical 
development (Fig. 3A).
PTPases have distinct expression patterns in adult tissues, with 
CPTP1 highly enriched in the brain.
In order to characterize the tissue distribution of the seven PTPases, we 
examined their expression in various aduit rat iissues and in five rodent cell
18
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lines. This analysis demonstrates that PTPase genes have overlapping yet 
unique expression patterns. In the adult brain, some of the PTPases are present 
at high abundance whereas others are barely detectable.
LAR mRNA is detected in many tissues with the highest levels in the lung, 
followed by brain, thymus, testis and ovary (Fig. 3B). The higher level of 
expression found in the thymus compared to the spleen is consistent with a 
higher level of expression by T-cells than by B-cells (Streuli et al., 1988). In 
addition to the three transcripts found in the cortex, a smaiier transcript that runs 
slightly above 18S rRNA is found in the lung, thymus, testis and myeloid 
leukemia cell lines. The "brain" lane on the tissue northern shown in Fig. 3B 
represents total brain RNA, rather than cerebral cortical RNA (as in Fig. 3A). 
Therefore, the relatively lower level of expression of the 6.0 and 8.0 kb bands 
compared to the 4.0 kb band is most likely due to the enrichment of the larger 
RNA species in the cortex compared to the rest of the brain, as recently reported 
by Longo et al. (1993).
LRP expression is higher in the brain than in the other adult tissues (Fig. 
3B). Lung and ovary have intermediate levels while heart and kidney have low 
levels of LRP mRNA. Leukemia cell lines also express significant levels of LRP.
RPTPyshows a more complicated tissue distribution (Fig. 3B). The high 
molecular weight transcripts seen in the cortex are present at equally high 
levels in the heart, lung, kidney and ovary. A previous study reported only the 
two high molecular weight transcripts by northern analysis of mouse tissues 
(Barnea et al., 1993). The long exposures used here to visualize RPTPy RNAs 
in muscle and testis also clearly show the 4.3 kb band in several tissues. 
However, consistent with the previous study of RPTPy expression (Barnea et al., 
1993), the lower molecular weight transcripts are present at dramatically lower 
abundance, except in the E16 cortex (Fig. 3A). The smallest molecular weight
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band found in the cortex appears io be brain specific. An even smalier 
transcript, running close to 18S rRNA, is found exclusively in the testis.
Initially we examined the expression of CPTP1 and P19-PTP in only two 
non-neural tissues, liver and kidney (Sahin and Hockfieid, 1993). This more 
extensive tissue analysis confirms our initial interpretations (Fig. 3B): the 6.5 kb 
transcript of CPTP1 is indeed neural-specific; it is not detected in any other 
organs or cell lines examined, even after long exposures. The 7.8 kb transcript 
is also found in the lung, muscie and testis, although at much lower levels than 
in the brain. Interestingly, the lymphocytic leukemia cell line, NF8D5, and the 
pituitary cell line, GC, predominantly express the 7.8 kb message. P19-PTP 
mRNA, as we described previously, is found in the adult brain but is not neural- 
specific; in fact, its abundance is much greater in the lung than in the brain (Fig. 
3B). Lower levels of P19-PTP are also detected in the kidney, testis and several 
cell lines.
PTP-1 message, which runs slightly below 28S rRNA, is only faintly 
detected in all lanes of the tissue northern containing 20 pg total RNA (Fig. 3B). 
This is consistent with the original report of this PTPase, in which detection of 
PTP-1 mRNA required 5 pg of poly-A+ RNA (Guan et al., 1990). Even with the 
faint signals we obtained here, the lung appears to express the greatest amount 
of PTP-1. This observation supports the results of a recent PCR experiment 
which identified many more copies of PTP-1 than any other PTPase in the lung 
epithelia (Rotin et al., 1994). Smaller transcripts of PTP-1 can be detected in the 
testis and in the fibroblast and myeloid leukemia cell lines.
SHP was originally cloned from a pre-B-cell line (Matthews et al., 1992). 
The tissue distribution demonstrates highest levels in the lung (as described by 
Plutzksy et al., 1992), followed by thymus, spleen and two leukemia cell lines. 
Although we detect a signal in the cortex blot (Fig. 3A), no signal is detectable in
20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the brain ians of the tissue blot. !n fact, no signal is detectable even in the iiver, 
which contains more SHP mRNA than the cortex (Fig. 3A). It appears, therefore, 
that the adult brain contains very low levels of SHP transcript. Given the high 
levels of SHP expression by hematopoietic cells, we initially speculated that the 
low level of expression detected in the cortex may be due to the presence of 
blood cells in the brain (Sahin et al., 1995). In fact by using an antisera to SHP 
(supplied by C. Siminovitch), we have detected the SHP protein in microglia 
and macrophages in the developing and adult brain (daia not shown).
PTPases have distinct expression patterns in the embryo.
Sagittal sections of E17 embryos were probed with radiolabeled 
antisense RNA corresponding to each of the PTPase domains used for northern 
hybridization. This in situ hybridization analysis gives an overall view of the 
expression pattern of each of the PTPases. Because each probe recognizes all 
the transcripts of each PTPase, this analysis cannot, of course, provide 
information about possible differences in expression of the different transcripts. 
As a positive control for neuronal RNA expression, near adjacent sections were 
probed with a clone for the middle subunit of neurofilament (NF) (Lewis and 
Cowan, 1986) (Fig. 4H). A sense probe for LAR was used as a negative control 
for non-specific hybridization and showed no hybridization signal (Fig. 41). At 
E17, cortical neurons are being generated in the ventricular zone, and newly 
born cells are migrating to their appropriate locations. Consistent with the 
northern analysis, many PTPases show high levels of hybridization to the 
embryonic cerebral cortex at this age.
Within the CNS, LAR is expressed at high levels in the cortex, midbrain, 
and spinal cord (Fig. 4A). In the developing cortex, the ventricular zone contains 
the highest levels of LAR expression. Outside of the CNS, LAR is expressed
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abundantly in the lung, thymus and skin. The labeling in the lung is punctate 
and probably associated with the bronchial system. LRP, in contrast, displays a 
more diffuse labeling pattern throughout the embryo, with approximately equal 
signals in the CNS and in many non-neural tissues (Fig. 4B). LRP expression 
within the CNS is also relatively uniform, with slightly higher levels of 
hybridization along ventricular zones and in the developing cortical plate. 
Unlike LAR and LRP, RPTPy labeling is higher in the midbrain, medulla and 
spinal cord than in the forebrain (Fig. 4C). In the midbrain (Fig. 5C) and cortex, 
RPTPy signal is found mostly in regions that contain post-mitotic neurons. At 
E17, RPTPy expression is higher in the CNS than in any other tissue in the 
embryo.
As will be described at length in Chapter 2, CPTP1 is expressed 
predominantly in the nervous system during the embryonic period. At E17, the 
highest CPTP1 transcript levels are detected in the developing cortex and 
midbrain (Fig. 4D). Similarly, P19-PTP mRNA is highest in the cortex and 
midbrain (Fig. 4E). P19-PTP is also detected diffusely throughout the rest of the 
embryo.
PTP-1 (Fig. 4F) and SHP (Fig. 4G) are both expressed at highest levels 
in the developing thymus. A lower, but still detectable level of PTP-1 is found in 
the cortex, midbrain and spinal cord of the E17 embryo (Fig. 4F). SHP is almost 
undetectable in the CNS, but is expressed at relatively high levels in the liver 
(Fig. 4G).
Neurofilament (Fig. 4H), a marker for differentiated neurons, is 
expressed at high levels in regions of the E17 spinal cord and medulla that 
contain post-mitotic, post-migratory neurons. It is expressed much less 
abundantly in the midbrain and cortex. This analysis indicates that expression 
of the genes for the PTPases begins before postmitotic neurons turn on the
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gene for NF. !n fact, some of the PTPases are most abundant in regions of high 
mitotic activity, which do not contain cells that have begun to express NF.
The nervous system expression of the PTPase genes is not restricted to 
the CNS. While not shown in the sections illustrated here, the dorsal root 
ganglia (DRGs) express the PTPases examined in the study. In particular, 
CPTP1, LAR, RPTPy, P19-PTP and PTP-1 are expressed at high levels in the 
E17 DRGs (data not shown).
At postnatal day 4, PTPases are preferentially expressed in the 
gray matter.
Sagittal sections of P4 brains were also examined by in situ 
hybridization, with the same series of probes used for the embryo sections. At 
this age, neurogenesis in most areas of the CNS is complete while glia 
continue to be generated (LeVine and Goldman, 1988). Neurogenesis 
continues in the cerebellum, where progenitors in the external granular layer 
give rise to granule cells. Meanwhile, neurite growth and synaptogenesis are 
ongoing processes throughout the brain.
In the P4 brain, LAR is expressed diffusely with highest levels in the 
cerebral cortex, hippocampus and cerebellum (Figs. 6A, 7B and 8B). All cortical 
layers including the subplate express LAR (Fig 7B). The subventricular zone 
also contains significant LAR mRNA. In the cerebellum, both the external and 
internal granular layers show LAR hybridization (Figs. 6A and 8B). Hybridization 
with a sense probe for LAR produces no signal (Fig. 61).
The distribution of LRP signal is similar to that of LAR (Fig. 6B). All layers 
of neocortex and the hippocampus display high transcript levels (Fig. 7C). 
Interestingly, LRP expression in the cerebellum is restricted to the internal 
granular layer and is absent from the external granuiar iayer (Fig. 8G).
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RPTPy mRNA distribution is markedly different from the other PTPases 
examined in this study (Figs. 6C, 7D and 8D). First of all, only the superficial 
layers of cortex contain high levels of RPTPy mRNA (Figs. 6C and 7D). 
Furthermore, RPTPy signal is much higher in the thalamus than in the striatum. 
Within the thalamus, the ventral and lateral nuclei contain the highest signal. 
There is no RPTPy mRNA in the subventricular zone (Figs. 6C and 7D). RPTPy 
also shows extensive expression in hippocampus and cerebellum. In the 
cerebellum, RPTPy is localized to both external and internal granular layers 
(Fig. 8D).
The mRNAs for CPTP1 (Fig. 6D), P19-PTP (Fig. 6E) and PTP-1 (Fig. 6F) 
are distributed in a pattern similar to that of LAR, with the cortex, hippocampus 
and cerebellum being areas with the highest levels of signal. Within the cortex, 
all layers including the subplate express all three messages (for CPTP1, see 
Fig. 7E). In the cerebellum, all of these PTPases are expressed in both the 
external and internal granular layers (for CPTP1, see Fig. 8E). SHP, on the 
other hand, is not detectable to any significant degree in P4 brain (Fig. 6G).
DISCUSSION
Using a PCR-based screen, we have characterized seven PTPases that 
are expressed at PO in the rat neocortex. Four are receptor PTPases (LAR, LRP, 
RPTPy and CPTP1), and three are non-receptor PTPases (PTP-1, P19-PTP and 
SHP). By northern and in situ hybridization, we have confirmed that the mRNAs 
encoding these PTPase sequences are indeed expressed in the cortex during 
embryonic and early postnatal life. This analysis permitted the identification of 
PTPases that are present at very low levels, such as SHP, as well as relatively 
abundant PTPases, such as CPTP1.
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PTPases are expressed at different relative abundance in the brain.
Although this study was not designed to compare quantitatively the 
expression of different PTPases, some statements about the relative abundance 
of these PTPases can be made. Comparisons between the in situ hybridization 
signals generated with identical amounts of equal length probes for each of the 
seven PTPases gives an approximation of relative expression levels. For the in 
situ hybridization, different exposure times were required for optimal detection 
of each PTPase. These differences reflect the relative abundance of the 
PTPases. For example, in E17 and P4 brain sections, the CPTP1 signal can be 
detected after an exposure of 24 hours while P19-PTP and PTP-1 signals can 
only be detected after 9 days (Figs. 4, 6). LAR, LRP and RPTPy produce signals 
of similar intensity after 4.5 days. Therefore, among the seven PTPases 
analyzed in this study, CPTP1 is likely to be the most abundant PTPase in 
embryonic and early postnatal brain, followed by LAR, LRP and RPTPy, 
expressed at about equal levels. P19-PTP, PTP-1 and SHP are expressed at 
the lowest levels of any of the PTPases studied here.
Receptor PTPases can transduce extracellular signals in the 
developing brain.
By northern and in situ hybridization, we have demonstrated that the 
receptor PTPases, LAR, LRP, RPTPy and CPTP1, are expressed in the 
developing central and peripheral nervous systems. Each of these receptor 
PTPases has a unique extracellular domain and two well-conserved 
intracellular catalytic domains. All four receptor PTPases described here were 
previously cloned and sequenced from non-neural tissue. This study is the first 
report of the spatial and temporal regulation of their expression during neural 
development. The structure of receptor PTPases suggest that they can function
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both as surface recognition molecules and as regulators of protein 
phosphorylation, which may be critically important during corticogenesis. 
Identification of their mRNAs and analysis of the spatial and temporal regulation 
of their expression during neural development can provide insights into their 
possible functions.
LAR contains three immunoglobulin (Ig)-like repeats and eight fibronectin 
type III (FN lll)-like repeats in its extracellular domain and thus resembles cell 
adhesion molecules like NCAM (Rutishauser, 1983) and TAG-1 (Furiey et al., 
1990). While immunocytochemistry with LAR antibodies showed no staining in 
the brain (Streuli et al., 1992), LAR mRNA can be detected abundantly in this 
tissue (this study; Longo et al., 1993). In fact, by PCR we find LAR mRNA in the 
brain as early as E13 (data not shown) and here show a high level of 
expression in proliferative zones in later embryonic stages. Therefore, LAR 
could be involved in homophilic interactions that regulate cellular proliferation 
and/or migration in the nervous system.
Unlike LAR, LRP does not contain cell adhesion molecule-like motifs. 
Instead, its extracellular domain, composed of 123 amino acids, has multiple 
glycosylation sites similar to the N-terminal region of CD45. Thus, it has been 
suggested that LRP may present carbohydrates to lectins (Matthews et al., 
1990). There is growing evidence that carbohydrates and lectins are involved in 
cell recognition and adhesion in the nervous system (Jessell et al., 1990). LRP 
mRNA is expressed at approximately equal levels throughout cortical 
development. Moreover, its distribution in the developing cerebellum coincides 
with the location of differentiated granule cells. Thus, LRP appears to be 
important for constitutive cellular functions that are not specifically associated 
with deveiopmentai events.
Unlike LRP, RPTPy has a large extracellular domain. The human RPTPy
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gene maps to a chromosomal region that is frequently deleted in lung and renai 
cell carcinomas (LaForgia et al., 1991). Its function in the developing brain is far 
from clear. However, our in situ data indicate that it is expressed by postmitotic 
neurons in the embryonic midbrain and cortex as well as in the postnatal 
cerebellum. The up-regulation of RPTPy during cortical development is 
consistent with expression by postmitotic cells and may indicate a similar tumor 
suppressor-like role in the CNS, perhaps to maintain neurons in a non-mitotic 
state. Interestingly, RPTPy and a similar PTPase, PTP£, both have extracellular 
domains with high homology to the enzyme carbonic anhydrase (Barnea et al., 
1993; Krueger and Saito, 1992). The extracellular domain of PTP£ is identical to 
a proteoglycan which can bind tenascin, NCAM and NgCAM (Barnea et al., 
1994a; Barnea et al., 1994b; Grumet et al., 1994). This raises the possibility of 
these PTPases being involved in cell-cell or cell-matrix interactions during 
maturation of the CNS.
As we suggested based on partial sequence homology (Sahin and 
Hockfieid, 1993), CPTP1 belongs to the LAR subfamily of receptor PTPases. 
CPTP1 has been cloned by four groups within the last year and has an 
extracellular domain that contains three Ig- and five FN Ill-like repeats 
suggesting homophilic binding properties (Walton et al., 1993; Pan et al., 1993; 
Yan et al., 1993). A liver cDNA sequence has three additional FN Ill-like repeats 
spliced into the extracellular domain (Zhang et al., 1994). Thus, the liver isoform 
of CPTP1 has an extracellular region very similar in length and domain 
structure to LAR. Unlike the six other PTPases described here, CPTP1 is the 
only one that is more enriched in the adult brain than in non-neural tissues. 
CPTP1 is expressed as early as E13 in the brain (data not shown), and its 
relative abundance is higher than any other PTPase that we have examined. 
Furthermore, it is most abundant in progenitor cells and developing neurons
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and may, therefore, be important in the early differentiation of neurons.
Possible roles of PTPases in neural development and function
Because their substrates and extracellular ligands (in the case of the 
receptor PTPases) have not yet been identified, the cellular functions of 
PTPases have been difficult to elucidate. However, available evidence 
indicates that the role of PTPases is more complex than simple reversal of PTK 
action. The expression patterns of the seven PTPases examined in this study 
suggest general hypotheses about their cellular functions in the CNS. In the 
neocortex, CPTP1 and P19-PTP show the highest levels of expression during 
the period of corticogenesis and then are subsequently down-regulated. LAR is 
also expressed at a high level in the proliferative zone of the cortex. Cellular 
interactions during proliferation can regulate the mitotic rate and alter the 
identity of the progeny (Reh and Kljavin, 1989; Gao et al., 1991; McConnell and 
Kaznowski, 1991). Thus, the PTPases expressed in the these zones may play 
roles in the regulation of proliferation and determination of neuronal fate.
In addition, it is becoming increasingly clear that tyrosine 
phosphorylation is important in regulating neurite outgrowth (Bixby and 
Jhabvala, 1993; Wu and Goldberg, 1993). Using cultures of embryonic DRGs, 
which express high levels of PTPases, we have shown that tyrosine 
phosphorylation affects neurite initiation and outgrowth (Fryer et al., 1993, Soc. 
Neurosci., abstract). The receptor PTPases, with their putative roles as cell 
adhesion and transmembrane signaling proteins, would be well suited to 
mediate surface recognition and axonogenesis. In contrast, other PTPases 
(LRP, RPTPy and the high molecular weight transcript for LAR) are expressed 
either at a constant level or at increasing levels through postnatal life, implying 
that they play a constitutive role in mature neurai functions. Consistent with this
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observation, recent studies in Aplysia indicate that PTPases can reguiate the 
function of ion channels and thus affect the excitability of mature neurons 
(Wilson and Kaczmarek, 1993). Results from other groups implicate tyrosine 
phosphorylation in the control of mammalian ion channels as well (reviewed in 
Siegelbaum et al., 1994).
Because of the complexity of cellular interactions in the developing 
CNS, a complete understanding of the role of PTPases in neural development 
still remains in the future. The diversity and abundance of PTPase genes 
expressed in the brain provides compelling evidence that PTPases are 
important players in the complex cell-cell interactions that regulate cell fate 
determination in the CNS. We believe that we still have not explored the full 
repertoire of PTPases expressed in the developing cortex. While a low- 
stringency PCR screen is quite sensitive for identifying rare messages, it is 
neither quantitative nor exhaustive because of the bias introduced by the choice 
of primers. This is demonstrated by the fact that at least two PTPases that are 
known to be expressed in developing cortex were not detected here: PTP£ (also 
known as RPTPp; Krueger and Saito, 1992; Levy et al., 1993) and syp (Feng et 
al., 1993). The results we present here, however, indicate that PTPases are 
important in neurogenesis. This detailed characterization of the expression of 
several PTPases in the CNS will now permit further genetic and biochemical 
analyses that will help decipher their precise roles in neural development.
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Figure 1. PCR primers were constructed frum the most conserved 
regions in the catalytic domain.
A. Three members of the transmembrane PTPase family are shown to illustrate 
the extent of similarity in their first phosphatase domains: human CD45 (Streuli 
et al., 1987), human LAR (Streuli et al., 1988) and mouse LRP (Matthews et al., 
1990). The alignments were produced using the BESTFIT function of the GCG 
program (Genetics Computer Group, 1991). Amino acids conserved among the 
three PTPases are indicated in bold. Regions selected for primers are shown in 
boxes.
B. Amino acid sequence used to generate the PCR primers.
C. Degenerate nucleic acid sequence of the primers.
30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A .
CD4 5 725 QOPRDETVD
LAR 1415 QGPLPETMG 
LRP 342 QGPKEETVN
DFWRMIW
DFWRMVW
DFWRMIW
EQKATVIVMVTRCEEGNRNKCAEYWPSMEEGTRAFGDVWKINQHKRCPDYIIQ 
EQRTATWMMTRLEEKSRVKCDQYWP. . ARGTETCGLIQVTLLDTVELATYTVR 
EQNTATIVMVTNLKERKECKCAQYWP. . DQGCWTYGNVRVSVEDVTVLVDYTVR
CD45 794 KLNI. . .VNKKEKATGREVTHIQFTSWPDHGVPEDPHLLLKLRRRVNAFSNFFSGPIW 
LAR 1482 TFALHKSGSSEKRE. . . . LRQFQFMAWPDHGVPEYPTPILAFLRRVKACNPLDAGPMW 
LRP 409 KFCIQQVGDVTNRKPQRLITQFHFTSWPDFGVPFTPIGMLKFLKKVKACNPQYAGAIW
HCSAGVG
HCSAGVG
HCSAGVG
RTGTY
RTGCF
RTGTF
B. V
DFWRMIW HCSAGVG
C. 5' GACTTCTGGAGAATGATATGG 3' 3' GTGACGTCACGACCACATCC
C G G C  A T T C
G
793
1481
408
861
1548
479
Re
pr
od
uc
ed
 
wi
th 
pe
rm
iss
io
n 
of 
the
 
co
py
rig
ht
 o
w
ne
r. 
Fu
rth
er
 r
ep
ro
du
ct
io
n 
pr
oh
ib
ite
d 
wi
th
ou
t 
pe
rm
is
si
on
.
Figure 2. PCR from a PG cortex library resulted in the identification 
of seven PTPase domains. Deduced amino acid sequences of the PCR 
products are shown. Sequences were aligned using the PILEUP function of the 
GCG program (Genetics Computer Group, 1991). Amino acids encoded by the 
PCR primers are not shown. Residues conserved among all seven clones are 
shown in black boxes. The intensity of gray shading indicates the degree of 
amino acid similarity. The order of the sequences reflects the level of homology 
between sequences, with highest homology at the top. The first four sequences 
belong to receptor PTPases while the last three belong to non-receptor 
PTPases. The clones are identical or highly similar to the sequences reported in 
the following references: LAR (Pot et al., 1991; Yu et al., 1992); LRP (Moriyama 
et al., 1992); RPTPy (Barnea et al., 1993); CPTP1 (Sahin and Hockfieid, 1993; 
Walton et al., 1993; Pan et al., 1993; Yan et al., 1993); P19-PTP (den Hertog et 
al., 1992; Yang et al.,1993; Sahin and Hockfieid, 1993); PTP-1 (Guan et al., 
1990); SHP (Matthews et al., 1992; Yi et al., 1992). The second catalytic 
domains of LAR and CPTP1 that were also identified in this screen are not 
shown here.
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Figure 3. Northern hybridization demonstrates that different 
PTPases have different developmental and spatial expression 
patterns. A. 25 p.g of total RNA extracted from cerebral cortex from animals at 
embryonic day 16 (E16), postnatal days (P) 0, 4,14, 30 and adult (AD) as well 
as from P35 liver (LIV) were run in formaldehyde-agarose gels and blotted onto 
nitrocellulose. The same blot was used for seven rounds of hybridization with 
six PTPase probes and a probe for cyclophilin. The LAR blot shown is of the 
same RNA samples, but run on a separate blot. Equai ioading of ianes was 
confirmed by probing both blots with cyclophilin (CYCLO), which showed the 
same loading levels on both blots. Multiple transcripts of several receptor 
PTPases are detected in the cerebral cortex (LAR, RPTPy, CPTP1). Some 
PTPases are down-regulated (CPTP1, P19-PTP) over the course of cortical 
development while others are up-regulated (LAR, RPTPy). B. 20 pg of total RNA 
isolated from various adult rat tissues and five cell lines was loaded in each 
lane. Tissues are: heart (HE), kidney (KID), lung (LU), whole brain (BR), thymus 
(THY), spleen (SPL), muscle (MUS), pancreas (PAN), liver (LIV), testis (TES), 
ovary (OV). Cell lines are: L929 mouse fibroblasts (FIB), WEHI3 mouse myeloid 
leukemia cells (MyL), NF8D5 mouse lymphocytic leukemia cells (LyL), GC rat 
pituitary cells (GC) and YAC mouse lymphocytic leukemia cells (YAC). The 
positions of 28S and 18S rRNAs are indicated by large and small arrowheads, 
respectively. Two separate blots that contained almost all the same RNA 
samples were used in this analysis. Equal loading of the lanes was confirmed 
by ethidium bromide staining and photographing the gel (the bottom panel).
This analysis demonstrates that some PTPases are present at high abundance 
in the adult brain: LRP, RPTPy and CPTP1. Others are barely detectable in brain 
(SHP). Of these PTPases, only CPTP1 appears to be substantially enriched in 
the nervous system relative to non-neural tissues.
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Figure 4. in situ hybridization demonstrates that PTPases are 
expressed in the CNS during embryonic development.
Near adjacent parasagittal sections of E17 animals were hybridized to 35S- 
labeled antisense RNA probes for (A) LAR, (B) LRP, (C) RPTPy, (D) CPTP1, (E) 
P19-PTP, (F) PTP-1, (G) SHP, (H) NF as a positive control and (I) sense probe 
for LAR as a negative control, and exposed to film. (A) At E17, a high LAR 
signal is detected in the cerebral cortex (c), midbrain (mb), spinal cord (s), lung 
(lu) and thymus (t). In the cortex, the labeling is highest in the proliferative zone 
immediately surrounding the lateral ventricle (v) and is much lower near the pial 
surface where postmitotic neurons reside. (B) LRP mRNA is present in both 
neural and non-neural structures. In the CNS, the highest level of labelling is 
seen in the cortex. (C) RPTPy mRNA is expressed at the highest levels in the 
midbrain and medulla. There is less, but still detectable labeling in the cortex 
and the spinal cord. (D) CPTP1 signal is detected at high levels in the cortex, 
midbrain and spinal cord. Both the ventricular zone and the cortical plate show 
high levels of CPTP1 signal. (E) P19-PTP mRNA is found at highest levels 
within the cortex surrounding the lateral ventricle and in the midbrain. (F) PTP-1 
signal is present at a low level throughout the CNS and at somewhat higher 
levels in the thymus. (G) SHP is virtually undetectable in the CNS, while high 
levels are present in the liver (liv) and thymus. (H) At E17, NF mRNA is 
expressed at higher levels in the spinal cord than the more rostral parts of the 
CNS. The midbrain and the cortex display very little signal. (I) The sense LAR 
probe, the negative control, shows no signal. Exposure times for these 
autoradiograms are as follows: CPTP1 (D) -1 day; LAR (A), LRP (B), RPTPy 
(C), NF (H) - 4.5 days; P19-PTP (E), PTP-1 (F), SHP (G), sense control (I) - 9 
days. (Scaie bar = 1 mm)
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Figure 5. in contrast to the other PTPases, RPTPy is expressed 
predominantly by post-mitotic neurons. Emulsion dipped slides were 
counter stained with cresyl violet and photographed under bright-field optics for 
cell localization (A) or under dark-field optics for visualization of silver grains 
generated by probes to LAR (B), RPTPy (C), and NF (D). (A) Parasagital 
section through the midbrain on E16 shows the different layers of the 
developing midbrain. The pial surface is toward the top; the ventricular surface 
is toward the bottom. The ventricular zone (v) is densely populated by 
proliferating cells while the zone of post-mitotic cells (arrow) is relatively cell 
sparse. (B) A corresponding section labeled with antisense LAR probe 
demonstrates that LAR mRNA is detected in both the mitotic and post-mitotic 
zones of the midbrain. (C) In contrast, RPTPy mRNA is predominantly localized 
to the region of post-mitotic neurons (arrow) and is almost absent from the 
ventricular zone. (D) Similarly, NF mRNA is abundant in the post-mitotic zone 
(arrow), but is absent from the venricular zone, consistent with its expression by 
post-mitotic, differentiated neurons. (Scale bar = 50 pm)
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Figure 8. PTPases are expressed in the eariy postnatal brain.
Parasagittal sections from P4 brains were hybridized to 35S-labeled antisense 
RNA probes for (A) LAR, (B) LRP, (C) RPTPy, (D) CPTP1, (E) P19-PTP, (F) PTP- 
1, (G) SHP, (H) NF as positive control and (I) sense probe for LAR as negative 
control, and exposed to film. (A) At P4, a high level of LAR signal is detected in 
the neocortex (c), cerebellum (cb) and hippocampus (h). In the neocortex, all 
layers including the subplate (arrow) contain LAR signal. (See also figure 6.)
(B) LRP signal is similar to that of LAR; it is most intense in the neocortex, 
hippocampus and cerebellum. (C) RPTPy mRNA is detected in a pattern 
different from LAR and LRP. Signal is most intense in the neocortex, 
hippocampus, thalamus (t) and cerebellum. Within the neocortex, the superficial 
layers contain the highest levels of RPTPy signal. (See also figure 6.) (D)
CPTP1 is abundant in neocortex, hippocampus, and cerebellum. The highest 
levels of P19-PTP (E) and PTP-1 (F) mRNA are also detected in the same 
regions as CPTP1. (G) SHP message is detected at very low levels in the brain. 
(H) NF is abundant in hippocampus, thalamus, cerebellum and brainstem. 
Within the neocortex, the highest signal is in the middle layers. (I) Sense probe 
for LAR shows no hybridization signal. Exposure times for the sections are as 
follows: CPTP1 (D), NF (H) -1 day; LAR (A), LRP (B), RPTPy (C) - 4.5 days; 
P19-PTP (E), PTP-1 (F), SHP (G), sense control (I) - 9 days. (Scale bar = 1 mm)
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Figure 7. Receptor rTPases in posinaiai cortex. Emuision dipped 
slides were counter stained with cresyl violet and photographed under bright- 
field optics for cell localization (A) or under dark-field optics for visualization of 
silver grains generated by probes for LAR (B), LRP (C), RPTPy (D) and CPTP1 
(E). (A) Parasagital section of P4 cortex counter stained with crestyl violet 
shows the different layers of neocortex (ll-VI) and the subplate (s), hippocampus 
(h), subventricular zone (svz; Luskin, 1993) and the white matter (wm). (B) A 
near adjacent section of P4 cortex hybridized with radiolabeled antisense LAR 
probe demonstrates that LAR mRNA is found in all layers of neocortex and 
hippocampus (h), as well as in the subventricular zone (svz). The subplate 
(arrow), while a relatively cell sparse layer, shows intense hybridization signal. 
There is no labeling in the white matter (wm). (C) LRP labeling is similar with 
highest levels detected in the hippocampus (h) and neocortex. (D) RPTPy is 
also expressed in the hippocampus (h). However, in contrast to other PTPases, 
RPTPy mRNA is far more abundant in the superficial layers of neocortex than in 
the deeper layers. The subplate also contains detectable labeling (arrow), 
however, the subventricular zone (svz) is virtually unlabeled by RPTPy. (E) 
CPTP1 mRNA is expressed abundantly in the neocortex, hippocampus (h) and 
subventricular zone (svz). (Scale bar= 200 pm)
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Figure 8. Receptor PTPases in postnatal cerebellum. (A) An emuision 
dipped slide counter stained with cresyl violet and photographed under bright- 
field optics demonstrates the cell layers in the P4 cerebellum: external granular 
layer (EGL), Purkinje cell layer (PC), internal granular layer (IGL). The EGL 
contains proliferating granular cell precursors while the IGL contains the post­
mitotic, post-migratory granular cells. (B) LAR mRNA is found in both the EGL 
and the IGL. (C) In contrast to other receptor PTPases, LRP is expressed 
exclusively in the IGL (double arrows). (D) RPTPy mRNA is detected in both the 
EGL (single arrow) and the IGL (double arrows). (E) Similarly, CPTP1 is found 
in the deep EGL (single arrow) and also in the IGL (double arrows). (Scale bar= 
100 pm)
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L
TWO PROTEIN TYROSINE PHOSPHATASE GENES,
CPTP1 AND P19-PTP, ARE EXPRESSED AT THEIR HIGHEST 
LEVELS DURING NEUROGENESIS AND EARLY NEURONAL
DIFFERENTIATION
SUMMARY
The first chapter described a PCR-based approached that allowed us to 
identify PTPase genes expressed in the rat cerebral cortex at birth. At the time of 
our study (February, 1992), three of the clones encoding putative PTPase 
domains were not identical to any sequences in the GenBank. We referred to 
these clones as Cortex-enriched Protein Tyrosine Phosphatases (CPTPs) 1, 2 
and 3 (Sahin and Hockfield, 1993). In this chapter, we examine the expression 
patterns of these three clones by northern and in situ hybridization. This 
analysis demonstrates that all three clones are enriched in the nervous system 
during embryonic and early postnatal days. Then, we provide evidence that 
CPTP1 and CPTP3 represent the two phosphatase domains of a single 
receptor PTPase gene, which we call CPTP1. Since the completion of our 
study, a full length murine cDNA sequence named P19-PTP, which is highly 
homologous to CPTP2, has been reported (Den Hertog et al., 1992). Thus, in 
this chapter we refer to this non-receptor PTPase gene as P19-PTP.
38
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Tyrosine dephosphorylation has been associated with cellular 
differentiation in a number of non-neural tissues. For example, during 
granulocytic differentiation of leukemia cell lines, phosphotyrosine residues 
decrease while PTPase activity increases (Frank and Sartorelli, 1988). There is 
growing evidence that dephosphorylation may play a significant role in 
differentiation of neural tissues as well. For example, NGF-induced neuronal 
differentiation of PC12 cells is associated with an increase in PTPase activity 
(Aparicio et al., 1992). In the Drosophila nervous system, three receptor 
PTPases are selectively expressed on subsets of developing axons (Yang et 
al., 1991; Tian et al., 1991; Hariharan et al., 1991). Perhaps of greatest interest 
in regard to possible roles in cell-cell signaling, many receptor PTPases 
(including those identified in the Drosophila nervous system) have fibronectin 
type III (FN-III) and/or immunoglobulin (Ig)-like domains in their extracellular 
domains, suggesting that they may have dual functions: cell adhesion and 
signal transduction.
While few PTPases have been reported in the developing brain, the level 
of tyrosine phosphorylation indicates that PTPases must be particularly active 
early in neurogenesis (Maher, 1993). Furthermore, the increasingly large 
number of PTKs with demonstrated expression during neural development (Lai 
and Lemke, 1991; Sanchez et al., 1994) implies that there may also be a large 
group of PTPases involved in neuronal growth and differentiation. To identify 
PTPases expressed in neonatal rat cortex, we performed PCR amplification 
under low stringency annealing conditions with primers corresponding to the 
conserved catalytic domains of previously reported receptor PTPases (Sahin 
and Hockfield, 1993; also see Chapter 1). In this analysis, three clones
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encoding putative PTPase domains contained sequences that were not 
identical to any PTPase genes in the databases. They also lacked significant 
identity to one another. We referred to these clones as Cortex-enriched Protein 
Tyrosine Phosphatases (CPTPs) 1, 2 and 3.
At the time of our study, the deduced amino acid sequences of CPTP1 
and CPTP3 showed the highest homology to human receptor PTPases LAR 
(Streuli et al., 1988) and HPTP5 (Krueger et al., 1990). CPTP1 was highly 
homologous to the first phosphatase domain of human LAR and HPTP5, while 
CPTP3 was almost identical to their second catalytic domains (Sahin and 
Hockfield, 1993). These data indicate that CPTP1 and CPTP3 belong to the 
LAR subfamily of receptor PTPases, but neither is identical to rat LAR.
On the other hand, the sequence of CPTP2 had the closest similarity to a
non-receptor PTPase, PEP (PEST-domain phosphatase) (Matthews et al.,
1992). During the preparation of our study, a full cDNA sequence of a 
phosphatase from murine P19EC cells (named P19-PTP) appeared in the 
GenBank. At the nucleic acid level, CPTP2 shows 93% homology to P19-PTP. 
The deduced peptide sequence of the phosphatase domain of P19-PTP is 
identical to the CPTP2 peptide sequence except for one amino acid (Den 
Hertog et al., 1992). The tissue distribution and developmental regulation of 
P19-PTP has not been reported, but based on size and sequence information, 
P19-PTP is likely to be the murine homologue of CPTP2.
In this chapter, we use the three CPTP clones as probes for northern and
in situ hybridization to examine the expression patterns of their respective
genes. This analysis demonstrates that the expression of all three PTPs is 
enriched in the nervous system during the embryonic and early postnatal 
periods. Then, we provide evidence that CPTP1 and CPTP3 represent the two 
phosphatase domains of a single receptor PTPase gene, which we call CPTP1.
40
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The temporal and spatial regulation of expression of the mRNAs identified by 
these sequences suggests that they encode proteins that may participate in 
neuronal development.
MATERIALS AND METHODS 
PCR Amplification
PCR amplification from cDNA was essentially performed as described Chapter 
1. The degenerate oligonucleotide primers used here were the same as those 
used in the previous study and correspond to the conserved catalytic domain 
amino acid sequences DFWRM(IA/)W (upstream) and HCSAGVG 
(downstream). A postnatal day zero (PO) rat occipital neocortex cDNA library 
was used as the DNA template for the amplification (Sahin and Hockfield,
1993). Twenty five pmol each of sense and antisense primers were used in 25 
pi reactions in Taq buffer (10 mM Tris-HCI pH 8.3, 50 mM KCI, 1.5 mM MgCl2, 
0.001% gelatin) with 0.6 units of Taq polymerase, 200 pM dNTPs and 25 ng of 
cDNA library as template. PCR was carried out in a Perkin Elmer DNA Thermal 
Cycler for 35 cycles. Each cycle included a 30 sec denaturation at 94°C and a 3 
min extension at 72°C. In order to facilitate the annealing of the degenerate 
primers, the initial five cycles included a 1 min annealing step at 37°C and a 
slow ramp (1°C per 4 sec) between annealing and extension. The subsequent 
30 cycles utilized 1 min annealing step at 45°C with no ramp. One microliter 
aliquots of the reaction were used to ligate the amplified fragments into the TA 
vector (Invitrogen). Plasmids with inserts were chosen by blue/white selection 
and examined by PCR with the original degenerate primers for the presence of 
PTPase domains. Inserts that gave a band of the appropriate size (350 bp) after 
PCR were sequenced by the dideoxy chain termination method (Sequenase, 
U.S. Biochemical) on both strands using M13 (-40) forward and reverse
41
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primers. Sequence analyses were conducted using GCG software (Genetics 
Computer Group, 1991). The PCR clones were then used for the northern and 
in situ hybridization analyses as described below.
RNA isolation and Northern hybridization
Total cellular RNA was extracted from various tissues of Sprague-Dawley rats 
using the guanidine thiocyanate/cesium chloride ultracentrifugation method 
(Bothwell et al., 1990). For the analysis of developmental regulation, the 
cerebral cortex was dissected from animals at embryonic day 16 (E16), 
postnatal day 0 (P0), P4, P14, P30 and adult, using care to exclude the 
underlying diencephalon and the hippocampus. RNA was similarly extracted 
from P0 and P35 liver; P35 kidney; P14 and adult spinal cord. Total (25pg) or 
poly A+ (1-2 pg) RNA was denatured in 2.2 M formaldehyde, 50% formamide,
1X MOPS buffer at 65°C for 15 min. RNA was resolved by electrophoresis on a 
1.0% agarose gel containing 2.2 M formaldehyde and 1X MOPS buffer, 
transferred to Zeta-probe (Bio-Rad) by capillary blotting and then baked (80°C) 
under vacuum for 2 hours. Hybridization was carried out in 7% SDS, 1% BSA, 
0.5 M phosphate buffer pH 6.8 (PB), 1mM EDTA for at least 8 hours at 65°C 
(Church and Gilbert, 1984). Hybridization solution contained 1-3 x 106 cpm/ml 
of probe made by random primed labeling of the PCR fragments for each 
PTPase clone (Boehringer Mannheim). For random priming, PCR fragments 
were either gel purified using GeneClean (American Bioanalytical) or isolated 
using Magic PCR Preps (Promega). After labeling with [32P]-dCTP (Amersham), 
the specific activity of the probes were 2-8x10® cpm/pg. After hybridization, 
filters were washed twice in 5% SDS, 0.5% BSA, 40 mM PB, 1 mM EDTA and 
four times in 1% SDS, 40 mM PB, 1 mM EDTA at 65°C for 20 min, Gyclophilin, 
which is preseni at a constant abundance throughout development (Lenoir et
42
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al., 1986), was used as a control for equai ioaaing of ianes. RNA molecular 
weight standards (GIBCO/BRL) were included on the blots to estimate the sizes 
of the transcripts. Densitometry of the autoradiograms was performed on the 
LKB Ultrascan XL system.
In situ hybridization
In situ hybridization was performed as in Martin et al. (1992) with minor 
modifications. Twelve micron frozen sections were thaw-mounted onto gelatin 
coated slides, post-fixed and dehydrated. Sections were prehybridized in 2X 
SSC, 50% formamide at 50°C for 1 hour. Tissues were then hybridized in 50% 
formamide, 1X Denhardt's, 0.75 M NaCI, 10% dextran sulfate, 15 mM DTT, 10 
mM Tris-HCI pH 7.5, 1 mM EDTA, 0.5 mg/ml tRNA, 100pg/ml salmon sperm 
DNA and 1-2 x106 cpm probe at 50°C for 8-12 hours. The [35S]-CTP (NEN) 
labeled probes were generated using the T7 and SP6 promotors in the TA 
vector and the Riboprobe system (Promega). Neurofilament-middle (NF-M) 
antisense and CPTP3 sense probes were used as positive and negative 
controls, respectively (Martin et al., 1992). The negative control did not give a 
signal. Following hybridization, the slides were treated with 20 ng/ml RNase A 
at 37°C for 30 min. Final washes were done in 0.1 X SSC, 0.1% p- 
mercaptoethanol at 65°C for 30 min. Slides were then exposed to Kodak XAR 
film for 24-120 hrs. Autoradiograms were used as negatives to print figures. To 
analyze the signal at higher resolution, the slides were dipped into emulsion, 
developed after 30-90 days and counter stained with cresyl violet.
RESULTS  
CPTPs recognize developmentallv regulated mRNAs in the rat
neocortex.
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The size, tissue distribution and deveiopmeniai expression of RNA 
species encoding the CPTPs were determined by northern blot analysis using 
the identified phosphatase domains. RNA samples isolated from rat neocortex 
at different embryonic and postnatal ages, as well as postnatal spinal cord, liver 
and kidney, were probed with radiolabeled PCR fragments for each CPTP. 
Confirmation of equal loading of the lanes was obtained by reprobing the blots 
for cyclophilin. Densitometry was used to determine the temporal regulation of 
the CPTP transcripts in the brain, where the ratio of absorbance of individual 
CPTP bands to that of the cyclophilin band was calculated for each RNA 
sample. Cyclophilin was used as a control because it is present at a constant 
relative abundance throughout brain development (Lenoir et al., 1986), in 
contrast to actin or tubulin whose relative abundance in the brain varies with 
age (Schmitt et al., 1977; Geschwind and Hockfield, 1989). Cyclophilin is not, 
however, expressed at equivalent levels in different organs. For instance, it is 
expressed at lower levels in the liver than in the brain (Danielson et al., 1988).
For CPTP1, two prominent transcripts are detected in the rat cortex, 6.5 
kb and 7.8 kb (Fig. 1A). The 7.8 kb message is preferentially expressed in the 
CNS, but is also weakly expressed in the liver and kidney. In the cortex, this 
message is the predominant transcript during embryonic life and is found at 
high levels at embryonic day (E16). The expression of the 7.8 kb transcript falls 
by postnatal day four (P4) and is relatively constant thereafter (Fig. 1E). In 
contrast, the 6.5 kb message is not detected in the E16 cortex. Its expression 
begins around birth, quickly approaches that of the 7.8 kb species during early 
postnatal days and remains relatively constant throughout the remainder of 
postnatal life (Fig. 1E). The 6.5 kb band appears to be neural tissue specific; it is 
not detected in RNA samples from adult liver (Fig. 1A). This species is similarly 
absent in RNA from adult kidney and PO liver (data not shown). Both transcripts
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for CPTP 1 are detected in postnatal spinai cord at ieveis simiiar to those found 
in postnatal cortex (data not shown).
For P19-PTP (CPTP2), a single mRNA species of 3.5 kb is observed (Fig. 
1B). In the cortex, this transcript is detectable at high levels at E16. The level of 
cortical expression declines around birth and remains close to adult levels after 
P4 (Fig. 1E). The level of expression of P19-PTP in adult cortex is similar to that 
in the adult liver (Fig. 1B), spinal cord and kidney (data not shown).
RNA detected with CPTP3 parallels CPTPi in size, tissue distribution, 
and developmental regulation (Fig. 1C and 1E). The CPTP3 probe hybridizes to 
two prominent bands at 6.5 and 7.8 kb. While the 7.8 kb band is more abundant 
in prenatal cortex, both bands are expressed at equal levels postnatally. The
6.5 kb form is not found in the liver. As discussed further below, the 
correspondence between the transcripts detected by CPTP1 and CPTP3 
suggest that they may represent the two phosphatase domains of a single 
PTPase gene.
CPTPs are expressed in the CNS during embryonic and postnatal 
development.
To determine the spatial distribution of CPTP mRNAs during 
development, we performed in situ hybridization using radiolabeled antisense 
RNA. Both embryonic and postnatal CNS tissues were analyzed by this method. 
Near adjacent sections were probed with neurofilament-middie (NF-M) as a 
positive control for neuronal RNA expression.
CPTP1: During embryogenesis, CPTP1 expression is higher in the 
nervous system than in non-neural tissues. CPTP1 mRNA is detected in E15 
embryos at high levels in the CNS (Fig. 2A). At this stage, CPTP1 mRNA is 
widely distributed in the CNS including the cortex, midbrain, medulla and spinal
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cord and peripheral!-/ in the dorsal root gangiia (DRG). At Ei5, many parts of the 
CNS do not exhibit a strong hybridization signal to NF-M probe (Fig. 2D). Thus, 
CPTP1 appears to be expressed before neurons start expressing 
neurofilament. By E17, CNS expression of CPTP1 has increased, with highest 
transcript levels detected in the developing dorsal telencephalon and midbrain 
(Fig. 2E). Around the lateral ventricles, the level of CPTP1 expression is higher 
in the developing cortex than in the ganglionic eminence. More caudal regions 
of the nervous system such as the spinai cord and DRGs express CPTP1, but at 
somewhat lower levels than in the cortex and midbrain.
During postnatal development, CPTP1 transcripts are detected non- 
uniformly in the brain. At P4, the highest levels of CPTP1 are found in the 
neocortex, hippocampus and cerebellum (Fig. 3A). Within the neocortex,
CPTP1 mRNA appears most abundant in the superficial layers and the subplate 
(Figs. 3A and 4B). This hybridization pattern is markedly different from the 
pattern of NF-M expression, where hybridization is most intense in the middle 
layers of the neocortex (Fig. 3D), correlating with a higher neuronal density. 
CPTP1 and NF-M also show different patterns of expression in the developing 
cerebellum. At P4, CPTP1 is expressed in both the external and internal 
granular layers (Figs. 3A and 4D) while NF-M appears to be excluded from the 
external granular layer (Fig. 3D). CPTP1 expression in the adult neocortex is 
lower than at P4 while adult hippocampus and entorhinal cortex continue to 
express this message at significant levels (Fig. 3E).
The expression of CPTP1 in the spinal cord follows a similar 
developmental regulation to that in the forebrain. CPTP1 is expressed 
throughout the rostro-caudal extent of the spinal cord at embryonic ages (Fig. 
2E). At P4, CPTP1 is expressed in the spinal gray matter, with somewhat higher 
levels of expression in the dorsal horn (Fig. 5A). NF-M is expressed at higher
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levels in the ventral than in the dorsal horn (Fig. 5D). At higher magnification, 
CPTP1 signal is seen associated with neurons (Fig. 4F). In the adult spinal cord, 
CPTP1 expression is diminished relative to early postnatal levels, but remains 
higher in gray matter than in white matter (Fig. 5E).
P19-PTP (CPTP2): P19-PTP mRNA is widely distributed in the 
embryo, but the highest in situ signals are found in the CNS, DRGs and liver. 
Within the CNS at E15 and E17, the telencephalon exhibits the strongest 
hybridization (Figs. 2B and 2F). Postnaiaiiy, neocortica! P19-PTP expression is 
markedly down-regulated. At P4, the P19-PTP message is still expressed in the 
cerebellar cortex, but there is only a weak and diffuse signal present in the 
neocortical gray matter (Fig. 3B). This low level of expression persists in the 
adult brain (Fig. 3F). Within the spinal cord, P19-PTP is found at high levels in 
the gray matter during early postnatal life. Hybridization is seen in both ventral 
and dorsal horns at P4 (Fig. 5B). In the adult spinal cord, the signal is less 
intense although still restricted to the gray matter (Fig. 5F).
CPTP3: The hybridization pattern of CPTP3 in the CNS generally 
follows the pattern of CPTP1. In the embryonic CNS, CPTP3 mRNA is detected 
at highest levels in the cortex and midbrain at both E15 and E17 (Figs. 2C and 
2G). Neocortical expression of CPTP3 persists into early postnatal life. At P4, 
the hippocampus and cerebellum also show strong hybridization to CPTP3. The 
CPTP3 expression in the cerebellum appears to be highest in the external and 
internal granular layers, similar to that seen with CPTP1 (Fig. 3C). In the adult, a 
diffuse signal is seen in the neocortex and hippocampus (Fig. 3G). In the spinal 
cord, CPTP3 is found throughout the gray matter at P4 (Fig. 5C). The distribution 
of the signal remains the same, but the intensity declines in the adult spinal cord 
(Fig. 5G).
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CPTP1 and CPTPS represent the two phosphatase domains of a 
single PTPase gene.
Virtually all transmembrane PTPases have two conserved intracellular 
phosphatase domains. The similarity between the first phosphatase domains of 
different PTPases is higher than that between first and second domains within 
any single phosphatase. The same is true for the second phosphatase 
domains. Interestingly, CPTP1 is highly homologous to the first, and CPTP3 to 
the second, catalytic domains of LAR and HPTP5. Moreover, CPTP1 and 
CPTP3 have almost identical developmental expression profiles on northern 
blots and very similar patterns of expression by in situ hybridization. These 
observations suggest that CPTP1 and CPTP3 may represent the first and 
second catalytic domains of a new receptor PTPase. In order to verify this 
possibility, PCR was used to screen for cDNAs that contain both CPTP1 and 
CPTP3. A non-degenerate oligonucleotide primer internal to CPTP1 
(corresponding to amino acids LATFCVR) and the degenerate downstream 
PTPase primer (see Chapter 1) were used to amplify cDNAs from the PO library. 
This amplification resulted in two PCR products with approximate molecular 
weights of 100 and 1100 bps (data not shown). Subcloning and sequencing of 
the large PCR product revealed that it contained CPTP1 sequences on the 5' 
end and CPTP3 sequences on the 3' end. The region in between CPTP1 and 
CPTP3 also showed high homology to rat and human LAR and to HPTP8 (82, 
84, 88% amino acid identity respectively). For simplicity, in the remainder of this 
paper, we consider CPTP1 and CPTP3 together and refer to them as CPTP1.
DISCUSSION
We have examined the expression of two PTPase genes in the 
developing rat CNS. By in situ hybridization we demonstrate that CPTP1 and
48
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
PI 9-PTP are expressed in the CNS by progenitor ceils and by developing 
neurons. In addition, the analysis of a longer cDNA clone indicates that CPTP1 
and CPTP3 represent the two phosphatase domains of a single PTPase gene.
CPTP1 gene encodes a novel receptor PTPase.
Recent PCR and low stringency hybridization studies have led to the 
identification of many novel PTPases (reviewed in (Fischer et al., 1991; Saito, 
1993; Pot and Dixon, 1992; Charbonneau and Tonks, 1992). Within the family 
of PTPases, two subfamilies have been characterized: low molecular weight 
cytoplasmic (non-receptor) PTPases and high molecular weight 
transmembrane (receptor) PTPases. With the exception of two (HPTPp and 
DPTP10D), all transmembrane phosphatases have two conserved intracellular 
phosphatase domains. The catalytic activity is associated with the domain 
proximal to the membrane while the second, more distal domain appears to 
have regulatory functions.
Both putative phosphatase domains of CPTP1 detect multiple high 
molecular weight transcripts, similar in size to receptor PTPases. In addition, 
they both show high sequence similarity to LAR and HPTP8, two receptor 
PTPases. Thus, the sequence of and RNA transcripts detected by CPTP1 
strongly suggest that it encodes a transmembrane PTPase. The in situ 
hybridization results presented here show that both domains of CPTP1 are 
expressed at very high levels in the developing brain. In particular, the 
ventricular zone of the cortical anlage at E15 and E17, where progenitor cells 
give rise to postmitotic neurons, is perhaps the highest region of CPTP1 
expression. Expression is markedly down regulated in the adult, suggesting that 
these putative PTPases may have a role in the proliferation and early 
differentiation of neurons.
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The putative phosphatase domains of CFTP1 are most simiiar io LAR 
and HPTP8, two receptor-like PTPases that are highly similar to one another 
(63% in the extracellular region, 88% in the intracellular region). The 
extracellular domains of LAR and HPTP8 contain three Ig-like repeats and eight 
FN Ill-like repeats (Saito and Streuli, 1991). The combination of Ig- and FN Ill- 
like repeats is also found in cell adhesion molecules like NCAM (Rutishauser, 
1983), fasciclin II, neuroglian (Grenningloh et al., 1990) and TAG-1 (Furley et 
a!., 1990), as well as in a tumor suppressor gene product, DCC (Fearon et ai., 
1990). The high degree of similarity among the phosphatase domains of 
CPTP1, LAR and HPTP8, leads to the prediction that the extracellular region of 
CPTP1 will also contain Ig- and FN Ill-like motifs. During the preparation of our 
report (Sahin and Hockfield, 1993), the full length sequence of CPTP1 was 
simultaneously identified from different tissues by four different groups, and so 
has also been named PTP NE-3 (Walton et al., 1993), PTP-P1 (Pan et al., 1993) 
and RPTP-cr (Yan et al., 1993), and LAR-PTP2 (Zhang et al., 1994). The full 
length sequence in fact does confirm the predicted structure of Ig- and FN Ill-like 
motifs. Such a structure might allow CPTP1 to play a dual role, cell adhesion 
and signal transduction, in neuronal differentiation in response to cell-cell or 
cell-matrix interactions.
CPTP1 may give rise to more than a single gene product.
On northern blots both putative phosphatase domains of CPTP1 
recognize multiple transcripts, with two prominent bands at 7.8 and 6.5 kb. The 
presence of multiple bands may be due to processing of mRNA from a single 
gene, to the existence of multiple genes encoding the CPTPs, or to cross­
hybridization to other mRNAs. Several lines of evidence support the first of 
these possibilities, i.e. the presence of differential splicing and/or
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poiyadenylation sites. First, on genomic Southern biots, carried out under high 
stringency conditions, CPTP1 hybridizes to a single gene. Second, it is not 
likely that the two bands represent cross-hybridization to other gene products, 
such as rat LAR, because the calculated melting temperature of CPTP1-LAR 
hybrids is lower than the stringency conditions used for the northern blots. In 
fact, all bands remain present when the stringency of the northern is increased 
by raising the wash temperature to 70°C. Taken together, these data indicate 
that the 6.5 and 7.8 kb CPTP1 transcripts represent two different mRNAs 
derived from a single gene, distinct from rat LAR.
Many receptor PTPases, including CD45 (Streuli et al., 1987), LAR 
(Zhang and Longo, 1995), LRP (Matthews et al., 1990), DPTP10D and 
DPTP99A (Yang et al., 1991; Tian et al., 1991), have variants with different 
splicing and poiyadenylation sites. Alternative splicing of the CD45 gene is 
particularly interesting because it occurs in the region encoding the 
extracellular domain of the molecule. Eight isoforms of CD45 are produced 
using all possible combinations of the three exons encoding the extracellular 
domain (Trowbridge, 1991). These isoforms are expressed by different cell 
types and may have different ligands (Thomas, 1989). Therefore, receptor 
PTPases have the potential to generate a large number of cell type specific 
isoforms by alternative splicing.
Alternative splicing within the CPTP1 mRNA has been reported by two 
different groups. Screening different libraries, Goldstein and colleagues have 
identified a liver cDNA that contains eight FN Ill-like repeats and a brain cDNA 
that contains only five FN Ill-like repeats. Thus, CPTP1 gene may undergo 
tissue-specific alternative splicing leading to two different size transcripts. In an 
effort to account for the multiple bands seen on the northern blots of cortex, we 
looked for these extra FN Ill-like repeats in the P0 cortex by PCR, but have not
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been able to detect their presence on ethidium bromide stained agarose gels 
(Daniel Wolf, M.S. and Susan Hockfield, unpublished observations). A more 
sensitive approach may be to do Southern blots with the deleted segments. In 
addition Stork and colleagues have shown that RNA processing in the 3' 
terminal of CPTP1 can lead to deletion of its second catalytic domain in tissues 
including the cortex. We do not detect this band in our northern blots and have 
not examined its distribution by PCR.
In summary, the identities of the muiiipie CPTPi bands on the northern 
blots are not known at present. Our results raise the possibility that different 
isoforms of CPTP1 may be expressed by different groups of neural cells. Until 
we obtain additional sequence of these transcripts, we will not be able to 
resolve possible differential distributions of the mRNAs. However, the 
differential temporal regulation of the two major CPTP1 transcripts is consistent 
with this hypothesis. The expression of 7.8 kb and 6.5 kb transcripts is regulated 
differently during neural development. On northern blots, the 7.8 kb band is 
expressed at very high levels in the embryonic cortex while the 6.5 kb is not 
detected in the cortex until after birth. The in situ signal detected in the CNS of 
embryos therefore reflects the expression of the 7.8 kb message, while the 
signal detected in postnatal brain most likely reflects expression of both 7.8 and
6.5 kb messages. The differential regulation of the two CPTP1 mRNAs suggests 
that the two transcripts may encode gene products with different functions 
during pre- and post-natal brain development.
In addition to RNA processing, isoforms of receptor PTPases can be 
generated by post-translational modifications such as glycosylation and 
proteolytic processing. The receptor PTPases CD45, LAR and LRP are all 
heavily glycosylated (Thomas, 1989; Yu et al., 1992; Sap et al., 1990), and 
glycosylation of CD45 is critical for ligand binding (Stamenkovic et al., 1991).
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The pattern of glycosylation of CD45 differs among different ceii types and 
changes with activation of lymphocytes (Thomas, 1989). Differential 
glycosylation is also known to regulate the adhesive properties of other cell 
adhesion molecules, such as NCAM (Doherty et al., 1990), and thus may play a 
similar role for receptor PTPases. Furthermore, proteolytic processing of 
receptor PTPases may also be important in regulating their functions. Both 
human and rat LAR are cleaved intracellularly into two polypeptides that 
associate with each other non-covaientiy on the ceii surface (Streuii et al., 1992; 
Yu et al., 1992). The extracellular 150 kd portion of LAR containing the Ig- and 
FN Ill-like repeats can be shed in cell culture (Streuii et al., 1992). Neither the 
mechanisms that regulate cleavage and shedding nor the effects of these 
phenomena on phosphatase activity are known.
P19-PTP is a non-receptor PTPase highly enriched in the 
embryonic CNS.
P19-PTP (CPTP2) recognizes a 3.5 kb message with sequence 
homology to non-receptor PTPases. Two other groups have isolated full length 
cDNAs of similar size from human colon (PTPG1; Takekawa et al., 1992) and 
from human skeletal muscle (PTP-PEST; Yang et al., 1993). By sequence 
homology, PTPG1 and PTP-PEST are the human homologs of the murine P19- 
PTP gene. In addition, two groups have recently reported PCR-generated 
clones with very high homology to our clone CPTP2. The deduced amino acid 
sequence of CPTP2 is identical to a sequence isolated from mouse myeloid 
leukemia cells (Yi et al., 1991) and is highly similar (one out of 107 amino acids 
different) to a sequence from rat kidney cDNA (Moriyama et al., 1992). Although 
the nucleic acid sequence was not reported, the molecular weight and tissue 
distribution of the mouse myeloid mRNA is simiiar to CPTP2. These sequence
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data strongly suggest that all these cDNAs represent a single, ubiquitously 
expressed, non-receptor PTPase.
One major difference between the mouse myeloid PTPase and CPTP2 is 
that the level of the myeloid PTPase expression was reported to be equal in all 
tissues examined, including fetal and adult brain (Yi et al., 1991). This is in 
contrast to the down-regulation of P19-PTP mRNA we report here. The 
difference may be explained by the use of p-actin as a control for equal loading 
of RNAs probed with the myeloid PTPase probe. In the brain, actin isoforms are 
expressed at much higher levels during development than in the adult (Schmitt 
et al., 1977). An actin control may, then, have resulted in an underestimation of 
the mouse myeloid PTPase mRNA in the fetal brain.
Non-transmembrane PTPases have been isolated from the brain by 
other groups. T-cell PTPase (Cool et al., 1989), rat PTPase-1 (Guan et al., 1990) 
and STEP (striatum enriched phosphatase, Lombroso et al., 1991) are 
expressed in the brain. Rat PTPase-1 is found at high levels in adult 
hippocampus while STEP is primarily expressed in the adult striatum. The 
developmental expression profiles of these genes have not been reported. At 
present, P19-PTP is the only putative non-receptor PTPase which shows 
preferentially high levels of expression in embryonic brain. Our in situ 
hybridization results show that the P19-PTP is expressed at highest level in the 
developing cortex during the embryonic period, the time of rapid cellular 
proliferation. As development continues, the level of P19-PTP expression in the 
CNS decreases so that only a low level of expression can be detected in the 
adult cortex or spinal cord. P19-PTP expression in the adult liver is about the 
same as in the adult brain, much less than the embyonic brain.
Potential roles for CPTF1 and PI 9-PTP in the developing brain.
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CPTP1 and PI 9-PTP both encode putative PTPases that are wiaeiy 
distributed in the developing CNS. Within the cortex, both P19-PTP and the 7.8 
kb transcript of CPTP1 show very high levels of expression during the period of 
corticogenesis. Both are also expressed at high levels in the external granule 
cell layer of the developing cerebellum and are down-regulated throughout the 
nervous system in adult animals. Such temporal regulation of expression 
suggests that these PTPases may be involved in proliferation, migration and 
early differentiation of neurons. The 6.5 kb CPTPi message is expressed at the 
same level throughout postnatal life, implying that it has a constitutive role in 
mature neural functions.
The role of intercellular interactions in normal physiological processes 
and during development is well established. With the identification of increasing 
numbers of cell-cell and cell-matrix adhesion molecules, greater insights into 
the molecular mechanisms underlying cellular interactions have been gained. 
For example, it has become increasingly clear that cell adhesion is not merely a 
matter of extracellular stickiness, but is a complex phenomenon involving 
transmembrane signaling and cytoplasmic responses. This has been 
demonstrated most clearly in the immune system. For instance, the binding of 
leukocytes to endothelium and of helper T cells to antigen presenting cells lead 
to intracellular reorganization mediated by second messengers (Kupfer and 
Singer, 1989; Springer, 1990; Butcher, 1991). Both events involve cell 
adhesion molecules of the Ig and integrin families. Similar signaling mediated 
by integrins is involved in adhesive functions of platelets (reviewed in Shattil 
and Brugge, 1991).
In the developing nervous system, the molecular mechanisms that 
underiie processes such as neuronal migration and axonal guidance are being 
studied in detail (Bixby and Harris, 1991; Hynes and Lander, 1992). While many
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ceil adhesion moiecuies have been shown to piay a roie in these processes, 
the signal transduction mechanism by which cell surface events are translated 
into cellular responses are poorly understood. Many cellular processes are 
regulated by protein phosphorylation, balanced by the competing activities of 
kinases and phosphatases. Cell-cell contacts and protein phosphorylation can 
reflect two components of a single process, as illustrated by genetic studies in 
Drosophila. Null mutations of either the cell adhesion molecule, fasciclin I, or a 
cytoplasmic PTK, abl, have iittie observable effect on the nervous system. 
However, embryos double mutant for fasciclin I and abl show a pronounced 
disorganization of the nervous system, presumably due to a developmental 
misrouting of growth cones (Elkins et al., 1990). The identification of two 
receptor PTPases expressed on subsets of growing axons in Drosophila further 
suggest that a PTPase might perform both cell-cell recognition and intracellular 
signaling functions during development (Yang et al., 1991; Tian et al., 1991); 
however, the test of such a hypothesis has not yet been reported.
In vitro studies of vertebrate neurons also suggest that tyrosine 
phosphorylation regulated by extracellular signals is involved in neurite 
outgrowth. Inhibition of PTKs by genistein facilitates substrate-induced neurite 
outgrowth (Bixby and Jhabvala, 1992). Furthermore, binding of soluble L1 and 
NCAM to growth cone membranes reduces tyrosine phosphorylation of tubulin 
(Atashi et al., 1992). Although the mechanism of the decreased phosphorylation 
is not known, PTPases may be involved by either directly dephosphorylating 
tubulin or by regulating the activity of the PTKs. PTPases such as CD45 and 
LRP have already been shown to regulate src-family PTKs (Sefton and 
Campbell, 1991; Zheng et al., 1992).
The distribution of the PTPases described here suggest a role in cell-cell 
communication early in neural development. In the developing cortex and
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brainstem, CPTP1 and P13-PTP are expressed in many areas, but both are 
most abundant in the regions immediately surrounding the ventricles, which are 
the site of cellular proliferation. While the cells that occupy the proliferative 
zones of the embryonic brain are largely homogeneous in appearance, they 
give rise to all of the phenotypically diverse types of neurons and glia in the 
mature brain (for discussion, see Geschwind and Hockfield, 1989). The 
mechanisms that control cellular differentiation have been the object of 
intensive study over the last several years. Reports from two laboratories 
indicate that some aspects of the ceil fate are determined as a consequence of 
signals transmitted and received during the terminal mitosis (Reh and Kljavin, 
1989; McConnell and Kaznowski, 1991). The potential dual roles of receptor 
PTPases as cell adhesion and transmembrane signaling proteins would be well 
suited to mediate this kind of signal transduction.
Receptor PTPases such as CPTP1 and non-receptor PTPases such as 
P19-PTP are new candidates which may play adhesion and/or signaling roles 
mediating the accurate assembly of the nervous system. It might be safely 
predicted that the full repertoire of PTPases expressed in the brain has not yet 
been explored. While the sequences we described here are expressed quite 
abundantly in the neonatal cortex and throughout the developing nervous 
system, members of the PTPase family expressed in more specific temporal and 
spatial patterns probably remain to be discovered.
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Figure 1. CPTP mRNA expression during development. Totai RNA 
extracted from cortex on embryonic day 16 (E16) and postnatal days (P) 0, 4,
14, 30 and adult (AD) as well as P35 liver (LIV) were run in formaldehyde- 
agarose gels, blotted onto nitrocellulose. The same blot was used for four 
rounds of hybridization separately with 32P-labeled cDNA probes for (A) 
CPTP1, (B) P19-PTP, (C) CPTP3, (D) control probe cyclophilin. The size of the 
transcripts were calculated using RNA molecular weight markers and are 
indicated at the left side of each blot. (E) Following exposure to the fiim, 
densitometry of the autoradiograms was performed for each transcript. To 
determine the relative abundance of each transcript in the RNA samples, the 
ratio of absorbance of each CPTP band to that of the cyclophilin band was 
calculated. In the graph, these values are presented as a percentage of the 
value in the adult cortex. According to this analysis, highest level of expression 
for P19-PTP and the 7.8 kb bands of CPTP1 and CPTP3 are found at E16. The
6.5 kb bands of CPTP1 and CPTP3 are detected at approximately equal levels 
in RNA samples from cortex at all postnatal ages, but are not detected in RNA 
samples from the E16 cortex or P35 liver.
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expressed in the CNS during embryonic development. Parasagittal 
sections from embryonic day 15 (A-D) and 17 (E-H) animals were hybridized to 
35S-labeled antisense RNA probes for CPTP1 (A,E), P19-PTP (B,F), CPTP3 
(C,G) and neurofilament-M (D,H) as control probe. (A) At E15, a high CPTP1 
signal is detected in the cerebral cortex (c), midbrain (mb), medulla (m). (B) 
P19-PTP mRNA is present throughout the CNS including the spinal cord. (C) 
CPTP3 mRNA is expressed at high levels in the cerebral cortex and the 
midbrain. There is less but significant labeling in the medulla and the spinal 
cord. (D) NF-M signal is detected at the sacral end of the spinal cord, but only 
weakly in the medulla and at even lower levels in the telencephalon. (E) At 
E17, CPTP1 mRNA is found at highest levels within the cortex (c) surrounding 
the lateral ventricle (v) and in the midbrain (mb). Lower signal is detected in the 
medulla (m), spinal cord (s) and the DRGs (d). (F) In a near adjacent section, 
P19-PTP message is detected throughout the CNS and in the DRGs, with 
highest expression in the cortex. (G) At E17, CPTP3 signal is seen at high 
levels in the cortex and at somewhat lower levels in more caudal regions of the 
CNS. (H) NF-M signal is expressed at higher levels in the DRGs than the CNS; 
a weak signal is detectable in the spinal cord and medulla and an even weaker 
signal in the cortex. (Scale bar = 1 mm)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
i - S  v • ' ___
* f  . J  "& •r^ *r * ‘ ^ - '■*■V  a, *v.\ ♦
€  ' ■
&  * -ft - ■;
l‘c.^  ->
^ ' l j
V;A i  r»«* « •
S 7>f$
I&.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3. CPTP expression in posinatai brain. Parasagitiai sections 
from postnatal day 4 (A-D) and adult (E-H) brains were hybridized to 35S- 
labeled antisense RNA probes for CPTP1 (A,E), P19-PTP (B,F), CPTP3 (C,G) 
and NF-M (D,H) as control. (A) At P4, a high level of CPTP1 signal is detected 
in the neocortex (c), cerebellum (cb) and hippocampus (h). Within the 
neocortex, signal is especially high in the superficial layers and the subplate 
(arrow). In the cerebellar cortex, two bands of CPTP1 signal are detected, in the 
external and internal granular iayers (see aiso Fig. 4D). in the hippocampus (h), 
all CA fields and the dentate gyrus exhibit high levels of CPTP1 hybridization.
(B) P19-PTP signal is seen most prominently in the cerebellum while the rest of 
the brain displays diffuse hybridization. (C) CPTP3 mRNA is detected in a 
pattern very similar to CPTP1 (in A). Signal is most intense in the neocortex, 
hippcampus, dentate gyrus and cerebellar cortex. (D) NF-M is abundant in 
neocortex, hippocampus, thalamus and cerebellum. Within the neocortex, the 
highest signal is in the middle layers. In the cerebellum, the most superficial 
layer (external granular layer) shows less signal than the deeper layers. (E) In 
adults, the highest levels of CPTP1 mRNA is detected in the CA fields of 
hippocampus, dentate gyrus and entorhinal cortex. The neocortex displays only 
a diffuse signal. (F) P19-PTP message is detected at very low levels throughout 
the brain. (G) CPTP3 mRNA is expressed diffusely in the neocortex and 
hippocampal formation. (H) NF-M message in the adult is most prominent in the 
hippocampus and neocortex, but is detectable throughout the brain. (Scale bar 
= 1mm)
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Figure 4. GPTP1 mRNA is detected irs neurons. Emulsion dipped slides 
were counter stained with cresyl violet and photographed under bright-field 
optics for cell localization (A, C, E) or under dark-field optics for silver grain 
visualization (B, D, F). (A and B) Horizontal section through the neocortex on 
postnatal day 6 demonstrates CPTP1 mRNA in all layers of the cortex with 
highest levels in layer 2-3 and the subplate (s). Much less label is detected in 
the underlying white matter (wm). (C and D) CPTP1 mRNA is detected at high 
level in the externa! (single arrow) and internal (double arrow) granular layers 
of the cerebellum at postnatal day 4. Between the two granular layers, the 
Purkinje cell layer is relatively devoid of hybridization. (E and F) In the ventral 
horn of postnatal day 4 spinal cord, CPTP1 signal is very high over neurons in 
the gray matter (arrows). Note that hybridization in the neighboring white matter 
(wm) is much less intense. Scale bars for A-D = 200 pm; for E and F = 100 p.m.
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Figure 5. CPTP expression is restricted to gray matter in the spinai 
cord. Transverse sections from postnatal day 4 (A-D) and adult (E-H) spinal 
cord were hybridized to 35S-labeled antisense RNA probes for CPTP1 (A,E), 
P19-PTP (B,F), CPTP3 (C,G) and NF-M (D,H) as control probe. At both ages, the 
sections for CPTP1 and NF-M are taken from cervical segments while those for 
P19-PTP and CPTP3 are from thoracic segments. (A) CPTP1 is expressed 
throughout the spinal gray matter, with somewhat higher levels of expression in 
the spinal dorsal horn. Expression of P19-PTP (B), CPTP3 (C) and NF-M (D) 
are similarly restricted to the gray matter. NF-M (D) is expressed at higher levels 
in the ventral hom. In the adult, CPTP-1 (E), P19-PTP (F) and CPTP3 (G) 
expression is diminished, but still greater in gray than in white matter. (H) At this 
stage, NF-M is highly expressed throughout the spinal gray matter. (Scale bar = 
1mm)
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CHAPitH 3
A PROTEIN TYROSINE PHOSPHATASE, PTPH1,
IS EXPRESSED IN A SEGMENT-SPECIFIC PATTERN 
IN THE RAT DIENCEPHALON
SUMMARY
PTPases that we have reported in the previous chapters are widely 
distributed within the rat brain. Here, we show that a non-receptor PTPase, 
PTPH1, is specifically expressed in the adult thalamus. Within the thalamus, 
PTPH1 expression is detected in most, but not all nuclei. Nuclei derived 
embryonically from the dorsal thalamus express this gene while those derived 
from the ventral thalamus do not. During development, PTPH1 expression is 
also greatly restricted to the dorsal thalamus as early as embryonic day 19. 
Taken together, these observation suggest that PTPH1 is a specific marker for 
the developing and mature dorsal thalamic nuclei.
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The mature brain of all species can be divided into different regions on 
the basis of distinct cellular and biochemical composition, patterns of 
connectivity and electrophysiological properties. While the regional 
organization of the mammalian brain is well established, the molecular 
mechanisms by which regional differences develop are largely unknown. One 
approach to this problem is to identify genes that are expressed in different 
regions.
The search for segment-specific genes has been successful first in the 
hindbrain and more recently in the forebrain. Studies of the hindbrain 
rhombomeres, a series of segmental bulges that give rise to brainstem 
structures (Hunt and Krumlauf, 1991), have revealed a number of genes that 
are expressed in rhombomere-specific patterns. For example, the expression of 
the putative transcription factor, Hox-b1, is restricted to rhombomere 4 (r4) 
(Wilkinson et al., 1989). The flanking rhombomeres, r3 and r5, express Krox-20, 
a transcription factor of the zinc-finger class. The forebrain also can be divided 
into a number of transverse segments based on morphology as well as 
expression patterns of regulatory genes (Rubenstein et al., 1994). For example, 
the diencephalon is made up of three segments named p1, p2 and p3 which 
respectively give rise to the pretectum, dorsal thalamus and ventral thalamus. 
Homeodomain containing proteins such as Dlx-1, Dlx-2 and Gbx-2 act as 
markers for each of these domains (Bulfone et al., 1993).
In addition to transcription factors, another group of genes likely to play a 
role in regional differentiation are those encoding proteins involved in 
intercellular signaling. In fact, four receptor protein tyrosine kinases (PTKs) that 
are expressed in rhombomere-specific patterns have been identified (Nieto et
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a!., 19S2; Henkemeyer et ai., 1394; Becker et ai., 1994). Aii four genes, named 
"segmentally expressed kinase" (Sek) 1-4, belong to the Eph subfamily of 
receptor PTKs, and each has an overlapping, but unique expression pattern in 
the hindbrain. This rhombomere specificity suggests that tyrosine 
phosphorylation may play a role in the regional specification of the mammalian 
brain.
Since the state of tyrosine phosphorylation is determined by the 
opposing actions of PTKs and protein tyrosine phosphatases (PTPases), one 
might expect PTPases also to be involved in regional specialization. Indeed, 
there is growing evidence that PTPases may play significant roles in regional 
differentiation. In Drosophila, three receptor PTPase genes are expressed by 
subsets of neurons during axonogenesis (Yang et al., 1991; Tian et al., 1991; 
Hariharan et al., 1991). Two of these, DLAR and DPTP99A, are relatively 
uniformly expressed in all of the developing connectives and commissures, 
while the third, DPTP10D, is enriched in the longitudinal connectives and 
anterior commissures. Similar to the Drosophila PTPases, a mammalian non­
receptor PTPase is predominantly expressed in the striatum and is designated 
"striatum enriched phosphatase" (STEP) (Lombroso et al., 1991). The gene that 
gives rise to STEP has at least two alternatively spliced forms. 4.4 kb message 
is present in many brain areas while 3.0 kb band is particularly enriched in the 
striatum.
Given the possible involvement of PTPases in neural development, we 
have investigated the expression of PTPase genes in the developing 
mammalian CNS (Sahin and Hockfield, 1993; Sahin et al., 1995). In this paper, 
we report that a non-receptor PTPase, PTPH1, is expressed in a regionally 
specific pattern in the rat brain. PTPH1 was originally cloned from HeLa cells 
and has homology to the cytoskeleton-associated proteins band 4.1, ezrin and
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iaiin (Yang and Tonks, i99 i). Here, we show that PTPH1 expression is 
markedly enriched in the thalamus in the adult rat brain. Within the thalamus, 
PTPH1 mRNA is expressed in most, but not all nuclei. PTPH1 is not expressed 
in nuclei that are embryonically derived from the ventral thalamus. During 
development, PTPH1 gene expression is specific to the dorsal thalamus as 
early as E19 and maintains this regional specificity throughout postnatal ages. 
These observations suggest that PTPH1 is an early and specific marker for the 
dorsai thaiamus and may play a role in its differentiation.
MATERIALS AND METHODS 
Northern Hybridization
For the analysis of tissue distribution, northern blots of RNA from various 
regions of adult Sprague-Dawley rat brains were generously supplied by Tony 
Ciaberra, Yale University. Total RNA was extracted from rat brain using RNAzol 
B (CINNA/BIOTECX), based on the method of Chomczynski and Sacchi (1987). 
Total RNA (20 pg/lane) was separated on a 1% agarose-formaldehyde gel and 
transferred to Biotrans(+) nylon membrane (ICN). Equality of loading levels was 
confirmed by adding ethidium bromide to each RNA sample and examining the 
28S and 18S rRNAs under UV illumination. Northern hybridization was carried 
out in 7% SDS, 1% BSA, 0.5 M phosphate buffer pH 6.8 (PB), 1 mM EDTA for 
18 hours at 65°C. Hybridization solution contained 1.2 x 106 cpm/ml of probe 
made by random primed labeling. After hybridization, the blot was washed twice 
in 5% SDS, 0.5% BSA, 40 mM PB, 1 mM EDTA and once in 1% SDS, 40 mM 
PB, 1 mM EDTA at 65°C for 15 minutes each. RNA molecular weight standards 
(GIBCO/BRL) were ran on the blot to estimate the sizes of the transcripts. The 
blot was exposed to Amersham Hyperfilm between two intensifying screens for 
7 days.
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Sn situ hybridization
In situ hybridization was performed as previously described (Sahin et al., 
1995). Twelve micron thick frozen sections were thaw-mounted onto gelatin 
coated slides, post-fixed in 4% paraformaldehyde (pH 7.4) and acetylated with 
0.5% acetic anhydride in 0.1 M triethanolamine (pH 8.0). They were then 
dehydrated in ethanols and delipidated in chloroform. Sections were 
prehybridized in 2X SSC, 50% formamide at 50°C for 1 hr, and then hybridized 
in 50% formamide, 1X Denhardt's, 0.75 M NaCI, 10% dextran sulfate, 30 mM 
DTT, 10 mM Tris-HCI pH 7.5,1 mM EDTA, 0.5 mg/ml tRNA, 100 pg/ml salmon 
sperm DNA and 1 x106 cpm probe at 50°C for 12-15 hours. The [35S]-CTP 
(NEN) labeled cRNA probes were generated using the T7 or T3 promoters in 
the Bluescript vector and the Riboprobe system (Promega). Following 
hybridization, slides were washed in 2X SSC, 50% formamide, 0.1% BME (p- 
mercaptoethanol) at 50°C, treated with 20 pg/ml RNase A, washed in 2X SSC, 
50% formamide, 0.1% BME at 58°C and in 0.1 X SSC/0.1% BME at 65°C for 30 
min each.
For initial localization of the probe, slides were exposed to film (Hyperfilm, 
Amersham) for 3-14 days. Autoradiograms were used as negatives for prints. 
For higher resolution analysis of probe distribution, slides were dipped in NTB-2 
emulsion (Kodak), developed after 35 days and counter-stained with cresyl 
violet. RPTPy antisense (Sahin et al., 1995) and PTPH1 sense probes were 
used as positive and negative controls, respectively.
RESULTS  
PTPH1 has a single transcript in the adult rat brain.
While conducting in a chromosome-walk on chromosome 9, several 
fragments of the PTPH1 gene were identified (Church et al., 1993). These
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fragments were cloned in Biuescript plasmid veciors and used to determine the 
tissue distribution of PTPH1 RNA. Clone D3 (bps 1337-1586) was chosen for 
this analysis because it lies in a portion of PTPH1 cDNA which does not show 
homology to other genes in the GenBank.
The expression of PTPH1 in different regions of the adult rat brain was 
determined initially by northern hybridization (Fig. 1). Hybridization with clone 
D3 reveals a single band of 4.4 kb, which is very close in size to the transcript 
detected in HeLa cell mRNA (Yang and Tonks, 1991). This band is detected 
only in the lane containing RNA from the adult thalamus. The RNA from other 
regions of the adult brain including amygdala, brainstem, cerebellum, cortex, 
hippocampus, hypothalamus, olfactory bulb, spinal cord and striatum do not 
produce a signal at an exposure time sufficient to give a strong signal in 
thalamus RNA. After much longer exposure times (30 days), very faint bands of 
the same molecular weight are detectable in the RNA from hippocampus and 
cerebellum (data not shown). These data indicate that D3 is a specific probe for 
PTPH1 gene on northern hybridization and suggest that PTPH1 expression is 
greatly enriched in the rat thalamus.
PTPH1 expression in the adult thalamus
To confirm the thalamus-enriched expression of PTPH1, in situ 
hybridization studies were performed using adult brain sections. Parasagittal 
sections of the whole brain were hybridized with antisense D3 probe. The 
labeling is most intense in the thalamus (Fig. 2A). Within the thalamus, the 
labeling is not uniform and is most intense in certain nuclei, including the 
medial geniculate nucleus, the lateral geniculate nucleus and the ventral basal 
complex. The hippocampus and cerebellum also show hybridization signal, but 
at much lower levels. As a control, a probe for RPTPy, a receptor PTPase, was
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used (Bamea et al., 1833; Sahin et ai., 1995). This phosphatase was chosen 
because it is expressed in the thalamus during early postnatal ages (Sahin et 
al., 1995). Hybridization with this receptor PTPase is highest in the adult cortex, 
especially in layer 4, as well as in the hippocampus (Fig. 2B). A much lower 
level of signal is seen in the adult thalamus. Hybridization with the sense probe 
for D3 produces no signal (Fig. 2C). These experiments show that the 
hybridization of D3 to the thalamus is specific and is different from other 
PTPases, which are more widely expressed in the brain.
Given that the distribution of labeling within the thalamus was not uniform 
in sagittal sections, a series of coronal sections of the thalamus were studied to 
identify the specific nuclei that contained PTPH1 RNA. To distinguish among the 
thalamic nuclei, emulsion dipped slides were counter stained with cresyl violet. 
Autoradiograms and high magnification micrographs are shown in Fig. 3 and 
the results are summarized in Table 1. In the most anterior sections examined 
(Fig. 3A), PTPH1 is expressed in the ventral medial, ventral posterior (VP), 
central median, mediodorsal and lateral dorsal thalamic nuclei. Labeling is 
absent from the reticular thalamic nuclei, zona incerta, subthalamus and 
habenula. In more posterior sections (Fig. 3B), PTPH1 labeling is again 
detected in the VP thalamic nuclei as well as in the dorsal lateral geniculate 
(DLG) and posterior (Po) thalamic nuclei. The superior thalamic radiation 
accounts for the gap between the VP and DLG nuclei. At this level, the ventral 
lateral geniculate (VLG) nuclei and zona incerta also show no labeling (Figs.
3D and E). Moving further posteriorly in the thalamus (Fig. 3C), the medial 
geniculate nuclei are the only are labeled diencephalic structures. Both ventral 
and dorsal medial geniculate (MG) nuclei contain PTPH1 labeling. At this level, 
the pretectum and superior coiliculi do not show any PTPH1 signal. In all these 
sections, pyramidal cells in fields CA 1-3 of the hippocampus and granular cells
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of the dentate gyrus show hybridization. Adjacent sections probed with 
antisense RPTPyand sense PTPH1 probe exhibited no signal in the 
diencephelon (data not shown).
PTPH1 is restricted to the dorsal thalamus during development.
We next examined PTPH1 expression during development by in situ 
hybridization with sections of brain starting at embryonic day 19 (E19). PTPH1 
RNA was detectable as early as E19 in the diencephalon in horizontal sections 
of the head (Fig. 4A). At this stage, hybridization is seen in the anlage of the 
dorsal thalamus and is absent from ventral thalamus (Figs. 4D and E; also see 
Jones, 1985). In addition to the diencephalic labeling, PTPH1 mRNA is also 
detectable at high levels in the olfactory epithelium at E19, but at very low levels 
in the neocortex and hippocampus. PTPH1 is also expressed in the dorsal root 
ganglia as early as E17 (Fig. 5). High levels of expression in the olfactory 
epithelium is consistent with the results of a previous PCR study that identified 
PTPH1 cDNA in the olfactory epithelium (Walton et al., 1993). By postnatal day 
eight (P8), PTPH1 signal is most intense in the thalamus compared to the rest of 
the brain (Fig. 4B). Neocortex and hippocampus express PTPH1 mRNA at low 
levels throughout the postnatal period. The thalamic-enriched expression of 
PTPH1 persists during the first two weeks of development (Fig. 4C). In 
summary, PTPH1 is expressed in a thalamus-enriched pattern throughout 
postnatal life.
DISCUSSSION
In this study, the expression pattern of a non-receptor PTPase, PTPH1, 
has been characterized. PTPH1 is highly enriched in the adult thalamus 
compared to other parts of the brain. Within the tnaiamus, the expression of
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PTFH1 is widespread, excluding oniy the ventrai iaterai geniculate and reticular 
thalamic nuclei. The thalamus-enriched pattern of expression is established as 
early as E19 and is retained throughout postnatal development. Taken together, 
these observations indicate that, like STEP, PTPH1 is a non-receptor PTPase 
that is expressed in a region-specific pattern in the mammalian brain.
Non-receptor PTPases have been isolated from the brain by other 
groups. PTPase-1 (Guan et al., 1990), syp (Adachi et al., 1992; Feng et al.,
1993; Ahmad et al., 1993) and STEP (Lombroso et al., 1991) are expressed in 
the brain. Previous studies have shown that syp, PTP1B and P19-PTP are 
widely expressed throughout the developing CNS (Feng et al., 1993; Sahin et 
al., 1995). In contrast, STEP and PTPH1 expression is restricted to the striatum 
and thalamus, respectively.
PTPH1 expression during segmentation of the diencephelon
Morphologically, the diencephelon can be divided into four segments: 
epithalamus, dorsal thalamus, ventral thalamus and hypothalamus 
(Coggeshall, 1964). Recently, three lines of evidence have demonstrated that 
the diencephelon is a segmented structure composed of several neuromeres 
similar to those in the hindbrain. First, clones of cell generated from a single 
precursor are restricted to one neuromere (Figdor and Stern, 1993). Second, 
adjacent groups of cells in different neuromeres do not mix (Figdor and Stern, 
1993). Finally, the expression patterns of certain regulatory genes respect 
neuromeric borders. For instance, Dlx-1 and Dlx-2 are preferentially expressed 
in the ventral thalamus during embryonic development while Wnt-3 and Gbx-2 
are expressed in the dorsal thalamus (Salinas and Nusse, 1992; Bulfone et al.,
1993). The diencephalic neuromeres thus identified have been designated as 
D1 through D4 by Figdor and Stern (Figdor and Stern, 1993) or P1 through P3
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by Rubenstein and Pueiies (Rubensiein et ai., 1994). in this discussion, we will 
use the numbering system from the Rubenstein and Pueiies neuromeric model.
PTPH1 is the first PTPase gene reported to be expressed in a segment- 
specific pattern in the diencephalon. Its expression in the adult thalamus 
includes all thalamic nuclei except for the ventral LGN and reticular nucleus. 
These two nuclei differ from the rest of the thalamus in two major ways: both are 
embryonically derived from the ventral thalamus and neither projects to the 
cortex (Jones, 1985). The oiher nuciei that make up the adult thalamus are 
derived from the embryonic dorsal thalamus and almost all have 
thalamocortical connections. Therefore, PTPH1 is expressed in all adult 
thalamic nuclei generated by the dorsal thalamus and is absent in the nuclei 
generated from the ventral thalamus. Furthermore, PTPH1 mRNA is not 
detected in the zona limitans which acts as the border between the dorsal and 
ventral thalami. The expression pattern of PTPH1 is most consistent with the 
location of the diencephalic neuromere P2. Although P2 contains both the . 
dorsal thalamus and the epithalamus, PTPH1 is absent in the epithalamus and 
habenula, and thus is restricted to a subsegment of P2.
The two other genes that are restricted to the P2 segment of the 
diencephalon are Wnt-3 and Gbx-2. Wnt-3 belongs to a family of secreted 
glycoproteins that are required for pattern formation in Drosophila and 
mammalian embryogenesis. For example, transgenic mice with null mutations 
of Wnt-1 gene lack a midbrain (McMahon and Bradley, 1990). Gbx-2 on the 
other hand is a transcription factor that belongs to the homeobox family (Murtha 
et al., 1991; Bulfone et al., 1993). While Wnt-3 is expressed in the epithalamus 
in addition to the dorsal thalamus, Gbx-2 and PTPH1 are restricted to the dorsal 
thalamus. Thus, PTPH1 expression overlaps more closely with the homeobox 
gene Gbx-2 than with Wnt-3.
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While PTPases have been shown to be expressed in region-specific 
patterns in the Drosophila and in the mammalian brain, there are differences 
between their expression in the two systems. First, unlike STEP and PTPH1, 
axon-pathway specific PTPases in the Drosophila are receptor PTPases. 
Second, subsequent to axonogenesis, the mRNAs for the Drosophila PTPases 
are down-regulated, strongly suggesting that they play a role in establishing, 
rather than maintaining, axon pathways. However, expression of STEP and 
PTPH1 are maintained in the aauit in a region-specific manner. Like PTPH1, 
Wnt-3 expression is also retained within the adult thalamus (Salinas and 
Nusse, 1992). The co-expression of Wnt-3 and PTPH1 in the adult thalamus 
suggests that these genes may also be involved in the maintenance of mature 
neural phenotype or function. Since the Wnt family of glycoproteins (Hinck et al.,
1994) and tyrosine phosphorylation (Behrens et al., 1994) both can regulate 
cell-cell adhesion by modulating cadherin function, it is tempting speculate that 
PTPH1 may be a part of the effector pathway for Wnt-3 in the dorsal thalamus. In 
this hypothetical model, the N-terminus of PTPH1, which shows homology to 
cytoskeletal proteins, might allow it to act on other cytoskeleton-associated 
proteins such as catenins, thus modulating cell adhesion and morphology.
In summary, this is the first report of a PTPase that is expressed in a 
segment-specific pattern in the diencephalon. The expression pattern of PTPH1 
demonstrated in this study provides further support for the neuromeric theories 
of forebrain development and suggests that PTPases may play a role in the 
regional differentiation of the nervous system.
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Table 1: Expression of PTPH1 mRNA 
in diencephalic nuclei
NUCLEUS PTPH1
RNA
Dorsal Thalamus
anterodorsal n. +
anteroventral n. +
anteromedial n. +
ventral medial n. +
ventral posterior n. +
central median n. +
mediodorsal n. +
lateral dorsal n. +
dorsal lateral geniculate n. +
posterior n. +
dorsal medial geniculate n. +
ventral medial geniculate n. +
Ventral Thalamus
reticular n. -
ventral lateral geniculate n. -
Zona Inserta -
Epithalamus
Habenula -
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Figure 1. Northern hybridization demonstrates that PTPH1 mRNA is 
particularly enriched in the thalamus. Total RNA extracted from different 
regions of the adult central nervous system is hybridized with probe D3. Only 
the lane containing RNA from the thalamus shows a band of 4.4 kb (top panel). 
Equal loading of the lanes is confirmed by ethidium bromide staining and 
photographing the gel. The rRNA visualized in this manner is shown in the 
bottom panel.
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Figure 2. in situ hybridization demonstrates that PTPH'i mRNA is 
largely restricted to the thalamus. Near adjacent, parasagittal sections of 
adult brains were hybridized with radiolabeled antisense RNA probes for 
PTPH1 (A) and RPTPy (B) and sense probe for PTPH1 as a negative control 
(C). (A) PTPH1 RNA is greatly enriched in the thalamus (t). Low levels of signal 
are seen in the hippocampus (h) and cerebellum (cb). (B) RPTPy RNA 
expression is highest in the hippocampus, and is also present in the neocortex 
(ctx), particularly in the middie iayers (arrow), and in the cerebellum. No signal 
is seen in the thalamus. (C) Sense probe for PTPH1 shows no signal in the 
brain. (Scale bar = 100 pm )
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Figure 3. PTPH1 is expressed in most, but net a!!, thalamic nueiei. 
Serial coronal sections of the adult thalamus were hybridized with radiolabeled 
antisense PTPH1 probe. (A) PTPH1 is detected in the ventral medial (VM), 
ventral posterior (VP), central median (CM), mediodorsal (MD) and lateral 
dorsal (LD) thalamic nuclei. Labeling is absent from the reticular thalamic nuclei 
(R) and habenula (ha). (B) PTPH1 is expressed in the ventral posterior (VP) as 
well as in the dorsal lateral geniculate (dLG) and posterior (Po) thalamic nuclei.
(C) In more caudal sections, the medial geniculate nuclei (MG) are intensely 
labeled.The superior colliculi (sc) do not show any PTPH1 signal, in all these 
sections, CA fields of the hippocampus (CA) and the dentate gyrus show low 
hybridization signal. (D and E) Emulsion dipped slide of a section near adjacent 
to (B) was counter stained with cresyl violet and photographed under bright- 
field optics for cell localization (D) and under dark-field optics for visualization of 
the silver grains generated by PTPH1 probe (E). PTPH1 signal is very high over 
neurons (arrows) in dorsal lateral geniculate (dLG) nucleus. In contrast, 
neurons in the neighboring ventral lateral geniculate (vLG) nucleus contain no 
labeling. White matter (wm) similarly shows no labeling (Scale bar for A-C = 1.5 
mm; for D-E = 25 pm).
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Figure 4. PTPH1 expression is restricted to the dorsai inaiamus
throughout development. Transverse section of E19 head (A) and coronal 
section of P8 (B), P15 (C) and adult (D) brains are hybridized with the 
antisense probe for PTPH1. (A) Within the E19 brain, the diencephalon (d) 
shows labeling for PTPH1 RNA. A much lower level of signal is detected in the 
cortex (c). Outside of the brain, the olfactory epithelium (oe) also exhibits 
intense PTPH1 signal. There is no labeling in the retina (r). (B) At P8, PTPH1 
mRNA is detected in the thalamus (t) and hippocampus. (C) By P15, PTPH1 
labeling is most intense in the thalamus. The hippocampus and entorhinal 
cortex show low levels of labeling. (D and E) Emulsion dipped and counter 
stained slide of a section near adjacent to that in (A) was photographed under 
dark-field illumination (D) for PTPH1 silver grain visualization and under bright 
field illumination (E) for cellular localization. PTPH1 labeling is detected in the 
dorsal thalamus (d), but not in the ventral thalamus (v). Anterior commissure (a) 
and third ventricle (3) are shown for orientation (Scale bars for A = 100 pm; for 
B-C = 100 pm; for D-E= 40 pm)
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Figure 5. PTPH1 is expressed in the embryonic dorsal root gangiia. 
Emulsion dipped slides were counterstained with cresyi violet and 
photographed under brightfield optics for cell localization (A) and under 
darkfield optics for visualization of silver grains generated by probes to PTPH1 
(B) and NF-M (C). (A) Transverse section through the lumber spinal cord at E17 
shows the spinal cord, dorsal root ganglia and the cartilaginous anlage of the 
vertebra. The dorsal surface of the embryo is on the top. (B) Same section 
under dark field optics demonstrates that PTPH1 mRNA is detected in the dorsai 
root ganglia at high levels. Very little label is found in the spinal cord or in the 
cartilage. (C) A near adjacent section labeled with antisense NF-M probe shows 
that NF mRNA is localized to the dorsal root ganglia as well as the spinal cord. 
Ventral horns contain more labeling than the dorsal horns. (Scale bar = 25 pm)
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Although the first PTPase was cloned only six years ago, the field of 
PTPases has flourished rapidly. While the research for my dissertation was in 
progress, knowledge about PTPase expression in different systems has 
expanded at a striking pace. The number of PTPase genes that have been 
identified to date may not be 1002 as some recent review titles suggest 
(Charbonneau and Tonks, 1992; Pot and Dixon, 1992), but is over 25 not 
counting the species homologs. Furthermore, different PTPase genes are 
known to to play a role in processes as diverse as cell morphology in 
Dictyostelium (Howard et al., 1993) to axon growth in Drosophila (Yang et al., 
1991; Tian et al., 1991; Hariharan et al., 1991), and ion channel regulation in 
Aplysia (Wilson and Kaczmarek, 1993) to hematopoesis in mammals (Shultz et 
al., 1993).
In this dissertation, I have reported the expression pattern of seven 
PTPases that are broadly distributed in the neonatal rat neocortex as well as 
one PTPase that is restricted to the dorsal thalamus. This chapter summarizes 
what we know about the structure and function of each of the PTPase genes 
expressed in the mammalian CNS. Six receptor and six non-receptor PTPases 
will be discussed below. This will be followed by description of a biochemical 
model of neurite outgrowth in which a putative role for PTPases is proposed. 
Finally, future prospects in this field will be reviewed with special focus on new 
experimental approaches.
RECEPTOR PTPases IN THE CNS:
Motivated by the identification of pathway-specific receptor PTPases in 
the Drosophila, several groups have sought to characterize receptor PTPases
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expressed in the mammalian brain. To date, these studies have identified at 
least six receptor PTPases, which fall into three groups based on the structure 
of their extracellular domains (Fig. 1). The first group includes LAR, CPTP1 and 
PTP8, all of which contain Ig- and FN Ill-like repeats. The second group consists 
of RPTPy and PTP£, which have carbonic anhydrase-like domains at the N- 
termini of their extracellular domains. The third group contains LRP, which has a 
very short extracellular region with no homology to other proteins. The 
expression and possible functions of each of these receptor PTPases in the 
nervous system are described here and summarized in Table 1.
LAR (Leukocyte common Antigen Related protein)
LAR is a widely-expressed receptor PTPase, which was first identified 
because of its homology to CD45, and was later shown to have PTPase activity. 
Greater than 95% of the PTPase activity of LAR is associated with the first 
catalytic domain (Pot et al., 1991). Using a variety of artificial substrates, the 
second domain has been shown to have no intrinsic enzymatic activity (Streuli 
et al., 1990). Thus, it was suggested to have a regulatory function. However 
since the in vivo substrates of LAR are unknown, the possibility that the second 
domain has PTPase activity with suitable substrates or that such an activity 
needs to be activated by so far unknown process cannot be ruled out.
The extracellular domain of LAR contains three Ig-like repeats and eight 
FN Ill-like repeats (Fig. 1). The combination of Ig- and FN Ill-like repeats is also 
found in cell adhesion molecules like NCAM (Rutishauser, 1983) and TAG-1 
(Furley et al., 1990), as well as in other receptor PTPases, PTPp (Gebbink et al.,
1991) and PTPk (Jiang et al., 1993). NCAM, TAG-1, PTPp and PTPk all display 
homophilic binding properties (Brady-Kalnay et al., 1993; Gebbink et al., 1993; 
Sap et a!., 1994). Thus, one might predict that LAR, ioo, can bind
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homophilically; however, io date there are no reports of binding assays showing 
such a property.
Another interesting feature of LAR is the existence of proteoiytically 
cleaved forms, which have been observed for both rat (Yu et al., 1992) and 
human LAR (Streuli et al., 1992). The extracellular 150 kDa portion of LAR 
containing the Ig- and FN Ill-like repeats can either be associated non- 
covalently with a transmembrane/intracellular portion on the cell surface or can 
be shed in cell culture. This cleavage occurs before the protein reaches the cell 
surface. The endopeptidase recognition site is five consecutive arginine 
residues located about 50 amino acids extracellular to the transmembrane 
domain. Proteolytic cleavage of LAR is not required for cell surface expression 
because mutations in the penta-arginine sequence prevent cleavage, but do 
not prevent surface expression (Streuli et al., 1992). Neither the mechanisms 
that regulate cleavage and shedding nor the effects of these phenomena on the 
phosphatase activity are known. Both NCAM and TAG-1 have membrane 
associated and soluble forms which have been suggested to play somewhat 
distinct roles in cell adhesion during neural development (Rutishauser and 
Jessell, 1988; Karagogeos et al., 1991). Thus, studies investigating the 
functions of soluble, as well as membrane-bound, LAR in the developing CNS 
will be essential.
The human LAR gene maps to chromosome 1 p32, a region that is 
frequently deleted in neuroblastoma and pheochromocytoma (Jirik et al., 1992). 
Although the gene structure for LAR has not been established yet, extensive 
cDNA analysis demonstrates that the LAR gene has many alternative splice 
sites. In the CNS, different cassettes of amino acids can be inserted into both 
the extracellular and the intracellular domains (Zhang and Longo, in press). 
Furthermore, northern hybridization with LAR shows three major transcripts in
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brain, with approximate sizes of 4.0, 6.0 and 8.0 kb. The ratio of expression of 
these three transcripts changes during cortical development (Chapter 1). In the 
embryonic cortex, the 4.0 kb transcript is the most abundant. During 
development, the 8.0 kb transcript is up-regulated, surpassing the smaller 
transcripts and reaching a peak in the adult cortex. The relative expression 
levels of the three transcripts is also different in different regions of the adult rat 
brain (Longo et al., 1993). The exact structure of the LAR gene that gives rise to 
these differentially-expressed transcripts awaits further studies.
While immunocytochemistry with LAR antibodies so far has shown no 
staining in the brain (Streuli et al., 1992), LAR mRNA can be detected 
abundantly in this tissue, both by northern and by in situ hybridization analyses 
(Longo et al., 1993; Sahin et al., 1995). In primary cultures, LAR is expressed by 
both neurons and glia; however, in the intact central and peripheral nervous 
systems, it is exclusively associated with cells with neuronal morphology 
(Longo et al., 1993). During development, LAR mRNA can be detected in the 
brain as early as E13 by PCR, and in situ hybridization shows a high level of 
LAR expression in proliferative zones at E17 (Sahin et al., 1995). Interestingly, 
LAR mRNA expression is up-regulated during NGF-induced neuronal 
differentiation of PC12 cells (Longo et al., 1993). Therefore, at least some of the 
diverse isoforms of LAR are expressed in patterns suggesting involvement in 
neuronal birth and in early stages of neuronal differentiation.
CPTP1 (Cortex-enriched Protein Tyrosine Phosphatase-1)
CPTP1 (Sahin and Hockfield, 1993) is a brain-enriched PTPase that was 
simultaneously identified from different tissues by six different groups, and so 
has also been named PTP NE-3 (Walton et al., 1993), PTP-P1 (Pan et al.,
1993), RPTP-o (Van et a!., 1993), LAR-PTP2 (Zhang e! al., 1994) and CRYPa
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(Stoker, 1894). Because one of the most importani features of inis gene is its 
brain enriched expression, we refer to it as CPTP1. The published full length 
CPTP1 cDNA clones all have 3 Ig-like and 5 FN Ill-like repeats (Fig. 1). More 
recently, a liver cDNA sequence that has three additional FN Ill-like repeats 
spliced into the extracellular domain of CPTP1 has been reported (Zhang et al.,
1994). Thus, the liver isoform of CPTP1 has an extracellular region very similar 
in length and domain structure to LAR. Interestingly, on northern blots of rat 
neocortex RNA, CPTP1 hybridizes to two bands of 6.5 and 8.0 kb (Sahin and 
Hockfield, 1993), suggesting that the difference between these bands might be 
attributable to the number of FN Ill-like repeats. In fact, there is preliminary 
evidence that two forms of CPTP1 differing in the number of their FN Ill-like 
repeats are expressed in the brain (Zhang et al., 1994). Furthermore, in PC12 
cells, there is a 4.8 kb transcript that is generated from the CPTP1 gene by 
alternative splicing (Pan et al., 1993). This isoform is identical to the full length 
sequence, except that it lacks the entire second PTPase domain. In the chick, 
CPTP1 homolog appears to give rise to at least four alternatively spliced 
transcripts (Stoker, 1994). Genomic southern analysis strongly suggests that 
there is only one CPTP1 gene (Walton et al., 1993; Sahin and Hockfield, 1993; 
Stoker, 1994), which is localized to mouse chromosome 17 (Yan et al., 1993) 
and human chromosome 19 (preliminary results, M.S., Susan Slaugenhaupt, 
Susan Hockfield). Therefore, multiple transcripts must reflect alternative splice 
and/or polyadenylation sites. Confirmation of this awaits more extensive 
genomic and cDNA analyses.
While most of the other receptor PTPases are widely expressed, CPTP1 
is markedly enriched in the adult brain compared to non-neural tissues. In fact, 
one of its transcripts (6.5 kb mRNA) appears to be exclusively expressed in 
neural tissues (Sahin and Hockfield, 1993; Stoker, 1994; Sahin et al., 1995).
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Moreover, while the 8.0 kb mRNA is detected in other tissues, it is expressed at 
a far greater level in the brain. In the adult CNS, CPTP1 is expressed in the 
hippocampus, neocortex, entorhinal cortex, olfactory bulb, cerebellum and 
spinal gray matter. During development, CPTP1 is detected throughout the 
developing CNS, including the retina, and in the dorsal root and trigeminal 
ganglia (Sahin and Hockfield, 1993; Yan et al., 1993). In all areas that have 
been studied, CPTP1 mRNA is associated with neurons, and not with glia 
(Walton et al., 1993; Sahin and Hockfield, 1993). In the olfactory epitheiium, 
CPTP1 is expressed by both neuronal precursors and mature sensory neurons 
(Walton et al., 1993). Similarly, within the embryonic forebrain, CPTP1 is found 
in both the proliferative zone and the cortical plate, indicating expression by 
neuronal precursors and by early post-mitotic neurons, respectively (Sahin and 
Hockfield, 1993). The detection of CPTP1 as early as E12-13 in the developing 
CNS is consistent with expression by progenitors and newly born neurons (Yan 
et al., 1993; Sahin et al., 1995). The possibility that CPTP1 plays a role in early 
neuronal differentiation is strengthened by the observation that CPTP1 mRNA is 
up-regulated during NGF-induced neuronal differentiation of PC12 cells (Pan et 
al., 1993).
Antisera raised against the extracellular domain of CPTP1 recognize two 
bands on western blots, at 100 and 200 kDa. The higher molecular band is 
thought to represent the full length protein product while the 100 kDa band may 
represent the proteolytically cleaved extracellular domain (Yan et al., 1993). 
However, unlike LAR, a cleavage site in the extracellular domain of CPTP1 has 
not been identified. Using a peptide located at the N-terminus of CPTP1, we 
have generated a rabbit antiserum that recognizes a 100 kd band on western 
biots (data noi shown), immunobiot staining can be blocked by the appropriate 
peptide, but not by an unrelated peptide. Although it is thought to correspond to
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the cleaved extracellular dornai n of CPTP1, the 100 kDa band is detected in the 
particulate, not in the soluble fraction of brain homogenates. This observation is 
consistent with the membrane association of this polypeptide in the lung (Rotin 
et al., 1994). Furthermore, the expression of this peptide follows closely the 
temporal and spatial distribution of CPTP1 mRNA, i.e. immunostaining is highly 
enriched in the brain and is down-regulated during development. While this 
antiserum appears to recognize the right protein product on western blots, it 
does not work for immunocytochemical localization of the CPTP1 protein. 
Interestingly, immunocytochemistry with antibodies raised to the chick homoiog 
of CPTP1 indicates that this protein is localized to growth cones of a subset of 
embryonic axons (Stoker et al., 1994, Soc. Neurosci., abstract), providing 
further evidence that CPTP1 may play a role in neurite outgrowth and axon 
guidance.
PTP8
While human PTP8 (HPTP8) was cloned in 1990 by Krueger et al., an 
analysis of tissue specific expression was not performed until the murine 
homolog (MPTP8) was isolated (Mizuno et al., 1993). While the full length 
amino acid sequence of MPTP8 shows 69% identity to LAR, its expression is 
strikingly different from LAR. LAR is found predominantly in T-cells and in cells 
of epithelial origin. In contrast, MPTP8 is restricted to brain, kidney, heart and B- 
cells. In the lung, where LAR is expressed at very high levels, MPTP8 is not 
detected (Sahin et al., 1995; Mizuno et al., 1993). Furthermore, MPTP8 maps 
close to locus b on mouse chromosome 4, which does not correspond to the 
chromosomal location of the human LAR gene. Therefore, despite high 
sequence homology to LAR, PTP8 appears to be a distinct gene.
Sequencing analysis of various cDNAs indicate that there are at least
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three transcripts of MPTP8 (Mizuno et al., 1993). All three transcripts share the 
same transmembrane and phosphatase domains, but differ in their extracellular 
domains (Fig. 1): type A contains one Ig-like and four FN Ill-like domains; type B 
contains one Ig-like and eight FN Ill-like domains; type C contains three Ig-like 
and eight FN Ill-like domains. So far, the three transcripts do not appear to be 
differentially expressed. Furthermore, an antiserum raised to a region shared 
among the three isoforms recognizes only one protein (about 210 kDa) on 
western blots (Mizuno et al., 1993). Therefore, it is not clear whether all three 
isoforms are translated into mature protein products. Further studies with 
isoform specific cDNA probes and antibodies will be required to answer this 
question.
In situ hybridization analysis with MPTP8 demonstrates that it is 
expressed in the adult hippocampus, thalamus and piriform cortex. However, to 
date there is no information about the expression of MPTP8 in the developing 
CNS. It will be very interesting to compare the expression patterns of the 
various LAR, CPTP1 and MPTP8 isoforms during CNS development.
PTP£
PTP£ (also known as RPTPp) has two phosphatase domains 
homologous to LAR, CPTP1 and PTP8, but has a divergent extracellular domain 
(Krueger and Saito, 1992; Levy et al., 1993). Instead of several Ig- and FN Ill- 
like repeats, the most N-terminal extracellular portion of PTP£ shows homology 
to the enzyme carbonic anhydrase (CA). This region is followed by one FN Ill- 
like repeat and a large cysteine-free domain that has no homology to other 
proteins (Fig. 1). Within the CA domain, the residues that are critical for zinc 
binding and catalytic activity of CA are missing from PTP£. However, this 
domain contains a hydrophobic pocket that has been suggested to be a binding
87
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
site for small molecules, including short peptides (Krueger and Saito, 1992).
Northern and cDNA analyses (Barnea et al., 1993; Barnea et al., 1994b) 
demonstrate that there are three transcripts of PTP£ (9.5, 8.5 and 6.4 kb), 
probably generated by alternative splicing from a single gene located on 
human chromosome 7q31-33 (Levy et al., 1993). The 9.5 kb transcript encodes 
the full length transmembrane form (Fig. 1). The 6.4 kb transcript also encodes a 
transmembrane isoform, but it lacks an 860 amino acid stretch in the cysteine- 
free extracellular region. The 8.5 kb transcript encodes a secreted form that 
corresponds to the full length extracellular domain of PTP£ without the 
transmembrane and intracellular domains. This isoform of PTP£ shows high 
homology to a previously identified rat proteoglycan, 3F8 PG (Barnea et al.,
1994b). Consistent with this homology, fibroblast cell lines transfected with the 
human 9.5 kb isoform express a chondroitin sulfate proteoglycan (Barnea et al., 
1994a). Thus, the 3F8 PG is likely to be the rat homolog of the secreted form of 
human PTP£. In aggregation assays, the 3F8 PG binds tenascin (Barnea et al., 
1994a; Grumet et al., 1994) and inhibits the homophilic binding of NCAM and 
NgCAM (Grumet et al., 1993), leading to the suggestion that at least some 
isoforms of PTP£ may also bind these neural cell adhesion and extracellular 
matrix molecules. So far, aggregation experiments have not been reported with 
any of the isoforms of PTP£. Somewhat paradoxically, an antisera raised to the 
C-terminal domain shared between the two transmembrane forms of PTP£ 
immunoprecipitates only a single high molecular weight species. Thus, the 
biochemical identification of the protein products corresponding to the 
alternatively spliced transcripts awaits further investigation.
Similar to CPTP1, PTP£ expression is restricted to the nervous system 
(Barnea et al., 1993), where it can be detected as early as E12 (Canoll et al., 
1993). The identity of the cells producing PTP£ has been controversial because
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of conflicting reports of mRNA expression: PCR shows PTP£ mRNA highly 
enriched in glioma, but not in neuroblastoma cell lines (Krueger and Saito,
1992); northern hybridization shows high levels in neuroblastoma, but not in 
glioblastoma cell lines (Barnea et al., 1993). Immunocytochemistry with antisera 
raised to the transmembrane forms of PTP£ indicates that it is highly expressed 
on radial processes of radial glia during development (Canoll et al., 1993).
PTPC, immunoreactivity is also associated with the glia of the embryonic optic 
stalk and of adult olfactory bulb axons, as well as with the Bergmann glia in the 
adult cerebellum. Preliminary evidence indicates that different isoforms of PTP£ 
are expressed by different types of glial cells (Canoll et al., 1994, Soc.
Neurosci., abstract). Thus, PTP£ appears to be expressed by various types of 
glial cells and could play a role in neuron-glial interactions.
RPTPy
Like PTP£, RPTPy has a large extracellular region containing a CA 
domain, a FN Ill-like domain and a cysteine-free domain (Bamea et al., 1993) 
(Fig. 1). The homology between PTP£ and RPTPy also extends into the 
cytoplasmic domains. Thus, these two PTPases define a subfamily of receptor 
PTPases, but extracellular ligands for RPTPy have not yet been identified. In 
contrast to PTP£, RPTPy is not restricted to the CNS. In the rat, RPTPy is 
expressed at about equal levels in the brain, heart, lung, kidney and ovary 
(Barnea et al., 1993; Sahin et al,, 1995). The human RPTPy gene (HPTPy) maps 
to a region on chromosome 3 that is frequently deleted in lung and renal cell 
carcinomas (Laforgia et al., 1991). These two lines of evidence have led to the 
suggestion that RPTPy may play a tumor-suppressive role in these organs.
The function of RPTPv in the* devplnninn bra'n is far from clear Northernt  • '  ■ ■* " • * * * “ • * • ( * * ■  * 5  ****• • • • W  •  • •  V I W M I  ■ I  V V I  » l  I W <  I I
blot analysis demonstrates two major high molecular weight transcripts around
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7.0 and 3.0 kb, and two minor transcripts with moiecuiar weights around 4.3 and 
3.3 kb (Chapter 1). The two major transcripts display parallel temporal 
regulation patterns, both reaching their highest levels in the second postnatal 
week and then gradually declining to adult levels. Especially intriguing is the 
brain-specific 3.3 kb mRNA, which is expressed at moderate levels at E16 and 
is then markedly down-regulated postnatally. The 4.3 kb mRNA does not 
appear to be temporally regulated. The cDNAs corresponding to each of these 
transcripts have not been identified. Perhaps of greatest interest is that the 
expression pattern of RPTPy in the CNS is unique among the PTPases. At E17, 
RPTPy is expressed at higher levels in the midbrain than in the cortex, while at 
P4 it is expressed at a higher level in the cortex than the midbrain (Chapter 1). 
During the embryonic period post-mitotic neurons express higher levels of 
RPTPy than do proliferating cells. Also unlike the other PTPases, in the early 
postnatal rat, RPTPy expression in the neocortex is restricted to the superficial 
layers (Sahin et al., 1995). Neurons in these layers are still migrating to their 
final position. Thus, RPTPy may be involved in neuronal migration. However, 
the fact that RPTPy mRNA levels increase over the course of cortical 
development suggests that its role may be more closely related to constitutive 
neuronal functions, perhaps serving a tumor suppressor-like function.
LRP (Leukocyte common antigen Related Phosphatase)
Unlike the rest of the receptor PTPases discussed in this chapter, LRP 
(also known as PTPa) has an extracellular domain that does not contain cell 
adhesion molecule-like motifs. Instead, its 123 amino acid extracellular domain 
has multiple glycosylation sites similar to the N-terminal region of CD45, 
suggesting that LRP may present carbohydrates to lectins (Matthews et al., 
1390). Like CD45, LRP could have different interactions and functions
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depending on its glycosylation pattern. This hypothesis will be testable when 
the carbohydrate groups present on LRP are identified, as recently reported for 
CD45 (Sato et al., 1993). It has already been shown that LRP cDNA can give 
rise to at least two protein species, which differ in their glycosylation pattern 
(Daum et al., 1994). Pulse chase experiments indicate that a smaller protein 
precursor gives rise to a larger form, although it is not known if the smaller 
precursor is expressed on cell surfaces.
CD45 and LRP are the only receptor PTPases for which the genomic 
structures have been completely elucidated. The gene structures of CD45 and 
LRP are strikingly similar in size and organization (Wong et al., 1993). The LRP 
gene maps to mouse chromosome 2 and contains 22 exons spanning over 75 
kb. The first and second phosphatase domains are made up of eight and seven 
exons, respectively. The active site (HCSAG) is found at the junction of two 
exons. Inclusion of exon 8, which encodes an 108 amino acid insert, into the 
first catalytic domain leads to diminished PTPase activity (Matthews et al.,
1990). A cDNA clone containing a 9 amino acid insert in the extracellular 
segment has been identified (Kaplan et al., 1990) from a human brainstem 
library. mRNAs with this insert are found in a variety of tissues, but at lower 
abundance than mRNAs without this insert (Daum et al., 1994). Because the 
protein products of the two cDNA are identical in size, PTPase activity and 
glycosylation pattern, the significance of the alternative splicing is not known. 
One possibility is that the two isoforms will show subtle differences in 
extracellular interactions, which may become clear once the physiological 
ligands are identified.
LRP is widely expressed in various tissues (Sahin et al., 1995), and the 
LRP promoter is simiiar to promoters found in widely expressed genes involved 
in cellular metabolism and growth (Wong et al., 1993). Among adult tissues, the
91
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
brain expresses the highest ievei o t  LRP. Lung and ovary nave intermediate 
levels while heart and kidney have low levels of LRP mRNA. In the developing 
cerebral cortex, LRP mRNA is expressed at relatively constant levels from 
embryos to adults (Chapter 1). Experiments with cell lines in vitro suggest a role 
for LRP in early stages of neural differentiation. LRP expression is up-regulated 
during neuronal differentiation of embryonal carcinoma and neuroblastoma cell 
lines (Den Hertog et al., 1993). Maximal expression of LRP is reached 
immediately before the neuronai phenotype is displayed, in addition, 
overexpression of LRP in P19 embryonal carcinoma cell line produces a higher 
incidence of neuronal differentiation and the acquisition of more mature 
neuronal properties such as electrical excitability (Den Hertog et al., 1993). 
Enhancement of src kinase activity in LRP-transfected cells is thought to 
underlie this effect. LRP is known to activate src in other cell lines like 
fibroblasts, possibly by dephosphorylating its C-terminal autoinhibitory 
phosphorylation site (Zheng et al., 1992). Expressed at about equal levels 
throughout development, LRP may have distinct roles in the developing and 
mature CNS.
Other receptor PTPases in the brain:
The list of receptor PTPases expressed in the developing mammalian brain has 
grown rapidly in the last few years. However, there is reason to believe that the 
full repertoire of receptor PTPases expressed in the developing CNS has not 
yet been revealed. For example, DPTP10D is expressed in the Drosophila 
CNS, but little is known about the expression of its mammalian homolog PTP(L 
CD45 has been reported to be expressed by both resting and activated 
microglia in human brain (Masliah et al., 1991). PTPe, a receptor PTPase with 
similarity to LRP, has been detected in the oifaciory epithelium by PCR (Walton
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et a!., 1S33), but its expression in the rest of the nervous system has not been 
examined. In addition to these previously cloned PTPases, there may also be 
as yet unidentified PTPases that do not contain the conserved sequences upon 
which PCR primers have been designed in the studies carried out so far. The 
identification of such PTPases awaits biochemical characterization and/or 
functional screening methods like those used to identify the first members of the 
PTPase family.
NON-RECEPTOR PTPases IN THE CNS:
Non-receptor PTPases characterized to date can be divided into five 
subfamilies depending on their sequence outside of the PTPase domains: (1) 
placental PTP1B (Chernoff et al., 1990; Brown-Shimer et al., 1990) and its 
homologs, T-cell PTPase (Cool et al., 1989) and rat PTP-1 (Guan et al., 1990); 
(2) striatum enriched phosphatase, STEP (Lombroso et al., 1991); (3) the SH2 
domain containing PTPases, SHP (Shen et al., 1991; Yi et al., 1992; Plutzksy et 
al., 1992; Matthews et al., 1992) and Syp (Hiraga et al., 1992; Freeman et al., 
1992; Adachi et al., 1992; Feng et al., 1993; Vogel et al., 1993; Ahmad et al., 
1993) (4) PEST sequence containing PTPases, PEP (Matthews et al., 1992) 
and P19-PTP (Den Hertog et al., 1992; Takekawa et al., 1992; Yang et al., 1993; 
Sahin and Hockfield, 1993); (4) PTPases with homology to cytoskeleton 
associated proteins, PTPH1 (Yang and Tonks, 1991), MEG (Gu et al., 1991), 
PTP36 (Sawada et al., 1994) and hPTPIE (Banville et al., 1994). Of these 
genes, PTP-1, STEP, Syp, SHP, P19-PTP and PTPH1 are known to be 
expressed in the brain and are discussed below:
PTP-1
Originally cionea from a hypothaiamic cDNA library, PTP-1 is the rat
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homolog of human PTP-1 B, which was the first biochemically purified PTPase 
(Charbonneau et al., 1989). PTP-1 sequence contains a catalytic domain at its 
N-terminus and a hydrophobic stretch of amino acids at its C-terminus (Fig. 2). 
Rat PTP-1 and human PTP1B sequences only differ significantly in their C- 
terminal ends. The C-terminus of PTP1B have been shown to be necessary and 
sufficient for its targeting to the cytoplasmic face of the ER (Frangioni et al.,
1992). Alternative splicing of PTP1B at its C-terminus has been reported 
although its effect on targeting to the ER is not clear (Shifrin and Neel, 1993). 
Thus, the subcellular localization of PTP-1 awaits further studies.
PTP-1 gene is located on human chromosome 20 and gives rise to a 3.5 
kb mRNA (Brown-Shimer et al., 1990). PTP-1 mRNA is broadly expressed in a 
number of tissues, at particularly high levels in the lung (Chernoff et al., 1990; 
Rotin et al., 1994). Within the CNS, PTP-1 mRNA is detected at E16 throughout 
the brain (Chapter 1) while in the adult it is restricted to the hippocampus (Guan 
et al., 1990).
STEP
STEP was originally identified by a subtractive hybridization approach 
looking for striatum specific cDNAs (Lombroso et al., 1991). Unlike most other 
non-receptor PTPases, the catalytic domain of STEP is located at the C- 
terminus (Fig. 2). The non-catalytic sequences of STEP are unrelated to 
sequences in the databases. The STEP gene has at least two alternatively 
spliced forms. The 4.4 kb mRNA is present in many brain areas while 3.0 kb 
band is particularly enriched in the striatum (Lombroso et al., 1991). 
Alternatively spliced STEP transcripts have been recently identified (Lombroso 
et al., 1994, Soc. Neurosci., abstract). These mRNAs give rise to four 
polypeptides (33, 37, 42 and 65 kDa) which vary in their subceiiuiar localization
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and rsgiona! expression patterns (Boulanger et al., in press). The three smaiier 
polypeptides are enriched in the soluble fraction, while the 65 kDa polypeptide 
is in the particulate fraction of brain homogenates. In the striatum, STEP is 
expressed by medium spiny neurons that receive dopaminergic input and co- 
localizes with DARPP-32. STEP protein is found in the cell bodies of these 
neurons as well as in their axon terminals in target areas such as substantia 
nigra. STEP immunoreactive cell bodies are also found in the nucleus 
accumbens, olfactory tubercle, lateral septal nucleus, and cortex (Lombroso et 
al., 1993). STEP is not detected in the embryo and is expressed in the striatum 
only after birth (Raghunathan et al., 1994, Soc. Neurosci., abstract). The 
relatively late developmental expression of STEP and its co-localization with 
DARPP-32 in dopaminoceptive neurons have lead to the suggestion that it 
plays a role in neurotransmitter signaling (Naegele and Lombroso, in press).
SHP
SHP has been identified by a number of groups from different tissues 
and given different names: PTP1C from breast carcinoma (Shen et al., 1991); 
HCP from myeloid cells (Yi et al., 1992); SH-PTP1 from megakaryocytes 
(Plutzksy et al., 1992); SHP from pre-B-cells (Matthews et al., 1992). Its 
sequence indicates an N-terminus containing two SH2 domains, followed by a 
catalytic domain and a short C-terminal non-catalytic segment (Fig. 2). The 2.6 
kb SHP transcript is expressed predominantly in hematopoietic cells, 
particularly in the thymus and bone marrow (Yi et al., 1992). However, it is also 
found in other tissues such as the lung and the brain (Chapter 1). Within the 
brain, SHP is expressed by cells of hematopoietic origin, such as microglia and 
macrophages.
SHP gene is located on human chromosome 12 and mouse
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chromosome 6 (Yi et a!., 1332). The human gene maps to a region associated 
with acute lymphocytic leukemias. In mice, an immunodeficient phenotype, 
motheaten (me), results from a loss-of function mutation in the SHP gene 
(Shultz et al., 1393; Kozlowski et al., 1993). Me mice do not produce any SHP 
protein and demonstrate severe defects in hematopoiesis and immune function, 
such as hyperproliferation of macrophages. Thus, it has been suggested that 
SHP may be an important negative regulator of hematopoietic cell proliferation 
possibly by modulating cytokine initiated tyrosine phosphorylation (Koziowski et 
al., 1993; Sun and Tonks, 1994). The defects in me mice also indicate that other 
non-receptor PTPases do not compensate for the loss of SHP activity and 
support the suggestion that different PTPases have specific substrates and 
functions within a cell. The effects of this mutation on SHP expression in the 
brain and on microglia phenotype are not known.
Given its pivotal role in hematopoiesis, structure-function analysis of SHP 
will be an intensely explored topic. SH2 domains are present in many 
molecules involved in signaling pathways and are known to bind specific 
phosphotyrosine residues (Songyang et al., 1993). Several studies have 
demonstrated that SH2 domains of SHP can interact with certain 
phosphotyrosine residues (Shen et al., 1991; Matthews et al., 1992; Vogel et al.,
1993). Multiple isoforms of SHP can be generated by alternative splicing at the 
5' terminus although the functional differences between the various isoforms 
are not known (Feng and Pawson, 1994).
Syp
Unlike SHP, which is expressed predominantly in hematopoietic cells, 
Syp (also known as PTPase L1, SH-PTP2, SH-PTP3, PTP1D, PTP2C) is 
expressed ubiquitously. Full length Syp cDNAs has been isoiatea from iiver
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(Hiraga et al., 1S82), brain (Freeman et ai., 1992), T-ceii iine (Aaacni et ai., 
1992), breast carcinoma cell line (Feng et al., 1993; Vogel et al., 1993), 
umbilical cord (Ahmad et al., 1993). Syp RNA is detected in embryonic heart 
and brain as well as adult brain, heart, kidney, liver, lung and spleen (Feng et 
al., 1993). On northern blots, a 6 kb transcript is detected. Open reading frame is 
only 1.8 kb while the rest of the transcript consists of a long 3‘ untranslated 
region.
The protein structure of Syp is similar to that of SHP: two SH2 domains at 
the N-terminal followed by a catalytic domain (Fig. 2). Thus, SHP, Syp and 
Drosophila PTPase corkscrew (csw) form a subfamily of non-receptor PTPases 
(Feng and Pawson, 1994). Interestingly, the C-terminal segment of Syp is more 
similar to corkscrew than to SHP, and like csw, it is expressed broadly. Thus, 
csw and Syp are probably species homologs, csw is known to act with raf in the 
signal transduction pathway initiated by a receptor PTK, torso (Perkins et al.,
1992). Syp can play a similar role by acting downstream of receptors for many 
growth factors including insulin, IGF-1 and EGF (Xiao et al., 1994). Interfering 
with Syp function in these systems results in a dramatic decrease in DNA 
synthesis and mitogenic signaling through growth factor receptors. The 
sequence of events in this pathway is thought to be as follows: Ligand binding 
causes autophosphorylation of the receptor PTKs. Syp binds 
autophosphorylated receptor PTKs, like EGF and PDGF receptors, Her2-neu 
and kit-SCF and gets tyrosine phosphorylated (Feng et al., 1993; Vogel et al.,
1993). Then, phosphorylated Syp acts as an adapter molecule and binds Grb2 
(Li et al., 1994; Bennett et al., 1994). GRB2 binding via Syp links ligand binding 
to the growth factor receptor to ras activation.
In addition to its role as as an adapter molecule, Syp plays a catalytic 
role in signaling as well. T he PTPase activity of Syp can be regulated by its
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interaction with receptor PTKs such that tyrosine phosphoryiation of Syp 
enhances its catalytic activity (Vogel et al., 1993; Uchida et al., 1994). 
Interestingly, Syp does not seem to dephosphorylate the PTKs that it associates 
with (Vogel et al., 1993). An RNA splice variant which contains four amino acid 
insert in the catalytic domain has been identified (Mei et al., 1994). This variant 
has lower catalytic activity indicating that alternative splicing may be a 
regulatory mechanism for PTPase activity. While its substrates have not been 
identified, Syp has been shown to preferentially dephosphorylate tubulin 
(Hiraga et al., 1992). With a putative role in FGF receptor signaling pathway 
(Sun and Tonks, 1994) and ability to dephosphorylate tubulin, Syp may also be 
involved in neurite outgrowth (see below).
P19-PTP
P19-PTP cDNA sequence indicates an N-terminal segment containing 
the catalytic domain and a C-terminal segment rich in proline, serine, threonine 
and acidic residues such as glutamate and aspartate i.e. a PEST sequence 
(Fig. 2). PEST sequences are also found in another PTPase, PEP, which is 
expressed primarily in hematopoietic cells (Matthews et al., 1992). Many 
nuclear proteins such as c-myc and c-fos contain PEST sequences, raising the 
possibility that P19-PTP and PEP may be nuclear. Recent experiments show 
that PEP is indeeed localized to the nucleus (Flores et al., 1994). Nuclear 
targeting signal is in the last 18 amino acids at the C-terminus of PEP. P19- PTP 
also contains a similar stretch of peptide sequence at the extreme C-terminus, 
suggesting that it also localizes to the nucleus. PEST sequences are 
characteristic of proteins with short half-lives; however, pulse-chase 
experiments show that PEP has a half-life greater than five hours (Flores et al., 
1984). Currently, both the subceiiuiar localization or the naif-iife of PI 9-PTP
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remain to be determined experimentally.
Like many PTPases, P19-PTP is a phosphoprotein. Phosphorylation by 
PKA or PKC on a serine residue decreases the phosphatase activity of P19- 
PTP (Garton and Tonks, 1994). P19-PTP expression is also highly regulated at 
the mRNA level. In P19 embryonal carcinoma cell system, P19-PTP mRNA is 
only expressed by cell aggregates, not by monolayers (Den Hertog et al., 1992). 
In skeletal muscle cell lines, insulin causes an increase of P19-PTP mRNA 
(Yang et al., 1993). At the same time, P19-PTP mRNA is broadiy distributed in a 
variety of tissues. Within the brain, its expression is highest during embryonic 
development suggesting a role during neuronal proliferation and early 
differentiation (Sahin et al., 1995).
PTPH1
PTPH1 sequence contains a N-terminal domain with homology to 
cytoskeleton-associated proteins such as band 4.1, ezrin and talin while its C- 
terminus encodes a phosphatase domain (Fig. 2). Because of its homology to 
cytoskeleton-associated proteins, it has been suggested that PTPH1 may "act at 
the interface between the plasma membrane and the cytoskeleton, for instance 
at focal adhesion plaques (Yang and Tonks, 1991)." This is a tempting idea 
because PTKs are heavily concentrated at such plaques. However, to date 
there is no report of its subcellular localization.
On northern blots probed with PTPH1, a single 4.3 kb band is detected in 
HeLa cells (Yang and Tonks, 1991) and in the thalamus (Chapter 3). The gene 
is located on human chromosome 9, close to the locus of familial dysautonomia 
(Blumenfeld et al., 1993). Given its expression in dorsal root ganglia during 
early development, PTPH1 is a good candidate gene for this disorder (Axelrod, 
1984; Pearson, 1984). However, currently no mutations have been detected in
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the open reading frame of PTPH1 in patients with familial dysautonomia (Susan 
Slaugenhaupt, personal communication). Whether there are mutations in the 
non-coding regions of PTPH1 remain to be determined.
FUNCTIONAL ROLES OF PTPases
While new members of the PTPases family are being cloned and 
sequenced at a staggering pace, the physiological roles played by these newly 
identified enzymes remain largely unknown. One obvious role is that PTPases 
can act as negative regulators and directly oppose the actions of PTKs in cells, 
as in the case of PTP1B blocking oncogenic transformation by PTKs (Brown- 
Shimer et al., 1992). This counter- regulatory role requires a dynamic balance 
between the activities of PTKs and PTPases, altering the phosphorylation state 
of cellular proteins. In contrast, PTPases can also take part in the same pathway 
and work in concert with PTKs. For instance, CD45 and LRP dephosphorylate a 
regulatory tyrosine on src family kinases to activate these PTKs (Koretzky, 1993; 
Zheng et al., 1992). Similarly, receptor PTKs phosphorylate non-receptor 
PTPases and modulate their activity (Vogel et al., 1993; Maegawa et al., 1994). 
Therefore, PTKs and PTPases may regulate each other by phosphorylation and 
thus act in a coordinated manner in cellular signaling. This is best demonstrated 
in the case of CD45 and T-cell receptor signaling (Chan et al., 1994).
CD45
The receptor PTPase that has been most extensively studied is CD45 
(reviewed in Koretzky, 1993; Trowbridge and Thomas, 1994). CD45, also 
known as Leukocyte Common Antigen (LCA), is expressed by all nucleated 
cells of the hematopoietic lineage. The CD45 gene gives rise to diverse 
isoforms by alternative splicing of exons m  l u u u in y  ihe o portion o t  tne
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extracellular domain as we!! as by a variety of differentia! giycosyiation patterns 
(Thomas, 1989). CD45 mRNA splicing is regulated in both a cell type-specific 
and developmental pattern and can be altered by T-cell activation (Janeway, 
1992; Trowbridge and Thomas, 1994).
Recent studies have sought to identify CD45's ligands, its intracellular 
associations and the mechanism of regulation of its catalytic activity. One CD45 
isoform expressed on helper T-cells, CD45RO, binds CD220 on B ceils 
(Stamenkovic et al., 1991). CD22JJ is a member of the Sg superfamily and is a 
lectin that interacts with a-2,6-linked sialic acids on many proteins including 
CD45 (Sgroi et al., 1993; Powell et al., 1993). Structural studies of CD45 have 
confirmed that at least some of its isoforms contain a-2,6-linked sialic acid 
residues (Sato et al., 1993). Thus, the binding of CD45 isoforms to CD22P or 
other ligands will most likely depend on their giycosyiation pattern. Meanwhile, 
there is no evidence that CD22p modulates the activity of CD45 (see 
Trowbridge and Thomas, 1994, for a detailed discussion).
Intracellularly, CD45 can activate the cytoplasmic PTKs, Ick and fyn, by 
dephosphorylating tyrosine residues in their regulatory domains (Woodford- 
Thomas and Thomas, 1993). Ick is associated with CD4 and CD8 while fyn is 
associated with the T-cell receptor (TCR) (for review see (Rudd et al., 1993; 
Chan et al., 1994)). The first biochemical effect of TCR stimulation is an 
induction of PTK activity (Saouaf et al., 1994). Since the TCR has no intrinsic 
PTK activity, it is thought that activation of non-receptor PTKs by CD45 mediates 
this step. Subsequent tyrosine phosphorylation of cytoplasmic proteins, in 
particular of phospholipase C, results in increased phosphotidyl inositol 
turnover, protein kinase C activation, a rise in intracellular calcium levels and 
cytoskeieiai reorganization. Ceii culture experiments with CD45' mutants and 
whole animal gene knock out experiments have shown that CD45 is essential
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for T-ceii aciivity and development (Koretzky, i 993; Desai et al., 1993; Kishikara 
et al., 1993). Aside from the TCR complex and non-receptor PTKs, CD45 seems 
to be associated with other cytoplasmic proteins. Some of these, like CD45-AP, 
are novel putative adapter proteins (Takeda et al., 1994) while others, like fodrin 
and spectrin, are well-known cytoskeletal elements (Lokeshwar and 
Bouguignon, 1992).
While extracellular and cytoplasmic interactions of CD45 are beginning 
to be understood, little is known about how the PTPase activity of CD45 is 
regulated. Intracellularly, the binding of fodrin to CD45 stimulates its PTPase 
activity (Lokeshwar and Bouguignon, 1992); however, the role of the 
extracellular domain is far from clear. By expressing just the intracellular portion 
of CD45 in CD45" cell lines, two groups have shown that the transmembrane 
and extracellular portions of CD45 are not required in the activation of T-cells by 
antibodies to the TCR (Hovis et al., 1993; Volerevic et al., 1993). Studies with 
chimeric proteins composed of the EGF receptor extracellular domain and the 
CD45 intracellular domain suggest that the CD45 catalytic domain is 
constitutively active (Desai et al., 1993; Desai et al., 1994). Furthermore, ligands 
for this chimeric protein, such as EGF, inhibit signaling through the TCR, 
possibly through dimerization of the chimeric proteins. This inhibition could be 
mediated by a decrease in PTPase activity of CD45 or by a blockade of its 
ability to interact with its substrates. So far there is no direct evidence for 
regulation of CD45 catalytic activity in response to EGF in this system. 
Interestingly, recent studies with fibroblast cell lines indicate that extracellular 
binding can modulate phosphatase activity of other receptor PTPases. In that 
case, PTPases are activated when cell-substrate adhesion is disrupted (Maher,
1993). This suggests that down-reg.ulation of catalytic activity by ligand binding 
may be a property shared by CD45 and other receptor PTPases. Unlike many
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other receptors including receptor PTKs, for which iigana binding activates 
signal transduction, signal transduction through receptor PTPases may be 
negatively regulated by ligand binding. Such a regulatory mechanism is quite 
attractive for PTPases because their intrinsic catalytic activities are strikingly 
high (Fischer et al., 1991).
Neurite outgrowth
Guided and stimulated by the progress in the immune system, the study 
of cellular interactions during neural development is an expanding area of 
research. Recently developed in vitro assay systems have facilitated the 
analysis of processes such as neuronal migration and neurite outgrowth (Rakic 
et al., 1994; Hynes and Lander, 1992). In both cases, it is becoming clear that 
complex and sometimes redundant molecular interactions underlie cellular 
events ranging from surface recognition/adhesion to transmembrane signalling 
to cytoskeletal modifications. We will briefly review the growing evidence 
suggesting that tyrosine phosphorylation/dephosphorylation plays a role in 
signal transduction pathways that regulate neurite outgrowth in both non­
vertebrate and vertebrate systems.
In Drosophila, null mutations of either the cell adhesion molecule, 
fasciclin I (fas I), or a cytoplasmic tyrosine kinase, abl, have little observable 
effect on the nervous system. However, embryos double mutant for fasciclin I 
and abl show a pronounced disorganization of the nervous system, presumably 
due to a developmental misrouting of growth cones (Elkins et al., 1990). This 
suggests that fas I and abl belong to two redundant and interacting pathways 
that converge on pathfinding in the growth cones. As already mentioned, other 
experiments performed in Drosophila have identified three transmembrane 
PTPases that are expressed on subsets of growing axons (Yang et ai., 1991;
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Tian et al., 1991; Hariharan ei al., 1S81) implying that iyrosine 
dephosphorylation is also involved in neurite outgrowth. Given the similar 
patterns of expression of abl and PTPases, it has been suggested that the 
PTPases may regulate the kinase activity of abl by modifying its 
phosphorylation state (Yang et al., 1991; Tian et al., 1991). So far, there is no 
direct evidence for any association between abl and the three Drosophila 
receptor PTPases.
Study of Aplysia neurons in culture indicates that tyrosine 
phosphorylated proteins are concentrated at the tips of growth cone filopodia 
and most likely associated with actin filaments (Wu and Goldberg, 1993). On 
growth promoting substrates, the phosphotyrosine staining of the filopodia tips 
is markedly reduced compared to less hospitable substrates such as polylysine. 
Conversely, inhibiting PTK activity with genistein decreases tyrosine 
phosphorylation and causes rapid elongation of filopodia. Removal of genistein 
is followed by shortening of the filopodia suggesting that actin filament 
dynamics are linked to the phosphorylation state of proteins in the growth cone. 
In this system, dephosphorylation increases neurite elongation while 
phosphorylation inhibits it. Some actin associated proteins, such as vinculin, 
can be phosphorylated in growth cones (Igarashi et al., 1990), providing a 
possible mechanism mediating cytoskeletal organization in response to 
extracellular substrates.
Several lines of evidence indicate that tyrosine phosphorylation can 
regulate neurite growth in similar ways in vertebrate neurons. First, cytoplasmic 
PTKs (src, fyn and yes) are enriched in growth cones (Maness et al., 1988;
Bixby and Jhabvala, 1993). These PTKs are expressed at much higher levels 
during axonal growth than in the adult. Furthermore, expression of a 
constitutively active v-src gene in PC12 cells results in neurite outgrowth in the
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absence of normally required NGF (Cox and fvianess, i993). Second, similar to 
Aplysia neurons, inhibition of PTKs by genistein facilitates substrate-induced 
neurite outgrowth in chick ciliary ganglion neuronal cultures (Bixby and 
Jhabvala, 1992), in NGF-primed PC12 cells (Miller et al., 1993) and in 
embryonic rat dorsal root ganglia cultures (Fryer et al., 1993, Soc. Neurosci., 
abstract). In goldfish retinal ganglion cell explants, genistein blocks antibody- 
induced axonal retraction (Finnegan et al., 1993). Thus, PTKs appear to be 
involved in both positive and negative regulation of neurite extension.
in order to assess the contribution of different PTKs to neurite outgrowth, 
Maness and her colleagues have analyzed neurite outgrowth from cells lacking 
a particular PTK. Comparisons between cerebellar granule cells from src, yes 
and fyn knock-out mice demonstrated that cells lacking src have impaired 
neurite outgrowth on the cell adhesion molecule L1 (Ignelzi et al., 1994) while 
those lacking fyn have a similar response on NCAM (Beggs et al., 1994).
Growth cone morphology and filopodial length were not altered in this assay, 
implying a lack of effect on actin dynamics. In addition, neurite outgrowth on 
laminin was not perturbed, suggesting a specific interaction between src and L1 
as well as fyn and NCAM. Interestingly, the same group previously 
demonstrated that binding of L1 or NCAM to growth cone membranes reduces 
tyrosine phosphorylation of tubulin (Atashi et al., 1992). Therefore, cell 
adhesion molecules like L1 and NCAM appear to act through src family kinases 
and at the same time reduce the phosphorylation of tubulin. These apparently 
contradictory results can be resolved if L1 binding activates a PTPase which, in 
turn, dephosphorylates a number of intracellular substrates, including tubulin 
and src.
As a result of their studies of neurite outgrowth on fibroblasts expressing 
neural cell adhesion molecules, Doherty and his colleagues have proposed
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that FGF receptor may mediaie the iniraceiiuiar signaling from cell adhesion 
molecules like L1 and NCAM (Doherty and Walsh, 1994). Since Syp has been 
shown to interact with FGF receptor and highly expressed in the developing 
nervous system, Syp may also be involved in neurite outgrowth. Although the 
exact molecular mechanisms are not understood, these data lend support to the 
idea that tyrosine phosphorylation and dephosphorylation, regulated by 
extracellular signals, are involved in neurite outgrowth.
Biochemical cascades involved in neurite outgrowth
The receptor PTPases identified so far are expressed at high levels in the 
immune and developing nervous system. In both of these cases, cellular 
interactions are crucial to the function and development of the system. Using the 
parallels between the two systems, we can speculate about the involvement of 
PTPases in the biochemical cascades underlying T-cell activation and neurite 
outgrowth.
Like T-cell activation described above, neurite outgrowth is most likely 
mediated by a combination of cell surface molecules (such as L1, NCAM, 
integrins) and second messenger systems (such as calcium or phosphorylation) 
(Schuch et al., 1989; Bixby and Jhabvala, 1990; Doherty et al., 1991; Williams 
et al., 1994; Doherty and Walsh, 1994; Bixby et al., 1994). The second 
messenger cascades in turn result in the cytoskeletal changes associated with 
neurite extension. It has been suggested that changes in phosphorylation states 
of actin and tubulin may mediate cytoskeletal dynamics. This leads to the 
following model: in a non-growing neurite, constitutively active receptor 
PTPases activate non-receptor PTKs. These PTKs in turn phosphorylate actin 
binding proteins and/or tubulin, which inhibits polymerization. When a growth- 
promoting extraceiiuiar iigand binds to the receptor PTPase, it is inactivated,
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resulting in the inactivaiion of non-receptor PTKs through autoregulation. A 
decrease in PTK activity would shift the equilibrium towards the non- 
phosphorylated forms of actin binding proteins and tubulin, which would lead to 
polymerization and neurite elongation. While highly speculative and certainly 
overly simplistic, this scenerio provides one useful way to think about how 
receptor PTPases might function in neurite outgrowth. Aspects of this model are 
testable by selective inhibition of different points in the biochemical cascade 
and assaying for the downstream effects.
FUTURE DIRECTIONS
Since the purification of the first PTPase in 1988, rapid progress in this 
field has placed PTPases in the center of several cellular processes. 
Nonetheless, several questions remain open. While motivated by the axon- 
specific patterns of expression in Drosophila, studies of PTPases (except for 
STEP and PTPH1) have not so far demonstrated similar cell-type or pathway 
specific expression in the mammalian CNS. One possibility is that there are 
other, as yet unidentified, PTPase genes that are expressed in more restricted 
patterns. Another possibility is that different isoforms of the genes already 
identified may have restricted distributions. We have reviewed here some of the 
evidence for the production of diverse protein isoforms from a single PTPase 
gene, either by RNA processing or by post-translational modifications such as 
giycosyiation and proteolytic cleavage. One exciting line of study will be the 
identification of the isoforms and the generation of specific probes with which to 
examine their distribution and temporal regulation. Antibodies raised to 
conserved domains of a PTPase can help identify a family of protein products 
that may have extracellular domains which differ in peptide sequences and/or 
giycosyiation patterns. On the other hand, isoform-specific antibodies will be
107
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
key to investigating differentia! localization and moiecuiar associations. These 
kinds of reagents will be useful in studies of the regulation of gene expression, 
both in vivo and in vitro.
Describing the regulation of diverse isoforms at the mRNA and protein 
level may provide clues to their cellular functions. However, to understand the 
biochemical cascades in which PTPases participate will require an 
understanding of their molecular interactions. Similar to that underway for 
CD45, the extra- and intra-celluiar interactions for each PTPase need to be 
examined. So far, putative ligands have only been identified for CD45, PTPp, 
PTPk and PTP£. However, ligand binding does not appear to alter the 
enzymatic activity of these PTPases. This is in striking contrast to the PTKs, the 
activity of which is regulated by either heterophilic (eg. trk) or homophilic (eg. 
Dtrk) binding. In order to find the extracellular ligands for receptor PTPases, 
expression screening studies may be helpful (Seed and Aruffo, 1987; Aruffo 
and Seed, 1987). It is important to note that such studies exploring ligands for 
CD45 have failed probably because ligand binding is strictly dependent on the 
giycosyiation patterns (Trowbridge and Thomas, 1994). Without the 
identification of such ligands, the regulation of signal transduction by receptor 
PTPases is doomed to remain a black box. On the other side of the membrane, 
the cytoplasmic interactions of the PTPases may be amenable to analysis by 
the yeast two hybrid systems (Fearon et al., 1992). However, because 
phosphorylation reactions may not require high affinity binding between the 
PTPase domain and its substrates, functional assays may provide a more direct, 
yet laborious, approach.
Another promising approach to understanding the functions of receptor 
PTPases is to look for alterations in specific cellular processes in the absence of 
PTPase expression. One straightforward approach is to use antisense
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oligonucleotides or cDNAs to decrease the expression of a particular PTPase in 
cultured cells. A more elaborate approach would be to introduce antisense 
cDNAs in vivo by retroviruses (Galileo et al., 1992). Finally, generation of null 
mutations in transgenic mice or in Drosophila should provide significant 
information about the function of specific PTPases. To date, there is no report of 
PTPase mutants in Drosophila. In mouse, only one isoform of CD45 has been 
knocked-out. Instead of completely turning off the synthesis of a protein, one 
can knock out a protein of interest in a specific subcellular location using a 
combination of intracellular antibodies and laser activation (Dan Jay ref). This 
approach may be particularly advantageous to analyze processes such as 
neurite outgrowth and neuronal migration where different regions of the cell 
may perform different functions. Interpretation of all these experiments can be 
complicated by the fact that there may be redundant pathways that might mask 
subtle deficits. Thus, challenging the cells that lack a certain PTPase to a range 
of conditions in vitro may be required to uncover their functions (Ignelzi et al., 
1994).
The abundance and diversity of PTPase genes expressed in the brain 
provides compelling evidence that PTPases are important players in the 
complex cell-cell interactions that regulate cell fate determination in the CNS. 
Because their substrates and extracellular ligands have not yet been identified, 
the cellular functions of PTPases have been difficult to elucidate. Potentially, 
each receptor PTPase may lead to the identification of still unknown cell 
adhesion molecules and novel signal transduction pathways. Therefore, from 
both the cell biological and neurobiological points of view, the study of receptor 
PTPases holds the promise of a wealth of information in the future.
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TABLE 1
PROPERTIES AND EXPRESSION PATTERNS OF SIX 
RECEPTOR PTPases EXPRESSED IN THE DEVELOPING RAT
BRAIN
PTPase LAR CPTP1 PTP8 PTP£ RPTPy LRP
chromosomal human mouse mouse human human mouse
location chr. 1 chr. 17 chr. 4 chr. 7 chr. 3 chr. 2
major mRNAs 
(kb)
8.0
6.0
4.0
8.0
6.5
7.0* 9.5
8.5 
6.4
9.0
7.0
3.5
E17CNS
cortex + + NA NA** + +
midbrain + + NA NA + +
spinal cord + + NA NA + +
P5 CNS
cortex (l-lll) + + NA NA** + +
cortex (IV-VI) + + NA NA - +
subventric. z. + + NA NA - -
hippocamp. + + NA NA + +
cereb(EGL) + + NA NA + -
cereb (IGL) + + NA NA + +
Adult
brain + + + + + +
lung + - - - + +
kidney - - + - + +
thymus + - - - - -
spleen - - - - - -
testis + - NA - - -
* Three species of mRNA all about 7.0 kb.
** See text for a discussion of PTP£ expression in the developing brain. 
NA= data not available.
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TABLE 2
PROPERTIES OF SIX NON-RECEPTOR PTPases 
EXPRESSED IN THE BRAIN
PTPase PTP-1 STEP SH P Syp P19-PTP PTPH1
other names PTP1B PTP1C
HCP
SH-PTP1
PTPase
L1
SH-PTP2
SH-PTP3
PTP1D
PTP2C
PTPG1
PTP-PEST
chromosomal
location
human 
chr. 20
human 
chr. 12; 
mouse 
chr. 6
human 
chr. 7
human 
chr. 9
mRNA size 3.5 3.0 2.6 6.0 3.5 4.3
alternative
splicing
yes yes yes yes no no
subcellular
location
? ER cytosolic/
membr.
cytosolic cytosolic ? nuclear sub-
membr.
enriched in hippo­
campus
striatum microglia dev. CNS dev. CNS thalamus
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Figure 1. Comparison of recepior FTPases expressed in the
developing CNS. Six receptor PTPases and their major alternatively spliced 
isoforms are shown schematically. The immunoglobulin (Ig)-like and fibronectin 
type III (FN lll)-like, carbonic anhydrase (CA)-like, and the phosphatase 
(PTPase) domains are represented specifically while the unique sequences of 
each protein is shown with a thick vertical line. The horizontal line crossing all 
the proteins represents the cellular membrane. For further details about each 
isoform and the respective references, piease see the text.
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Figure 2. Comparison of non-receptor PTPases expressed in the 
brain. Six non-receptor PTPases are shown in schematic form. The SH2, 
PEST- sequence containing, cytoskeleton-associated (ezrin)-like and PTPase 
domains are represented specifically. Sequences that have no homology to 
other cDNAs in the database are shown with a thick vertical line. The horizontal 
line above the six proteins represents the plasma membrane. Some of the 
PTPases may be associated with the plasma membrane or the ER. For further 
details and references, please see the text.
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